
<!doctype html>
<html lang="en" class="no-js">
  <head>
    
      <meta charset="utf-8">
      <meta name="viewport" content="width=device-width,initial-scale=1">
      
      
      
      
      <link rel="icon" href="../assets/images/favicon.png">
      <meta name="generator" content="mkdocs-1.1.2, mkdocs-material-7.1.6">
    
    
      
        <title>Enum: enum_CCDH_Substance_substance_type - CRDC-H Model in LinkML documentation</title>
      
    
    
      <link rel="stylesheet" href="../assets/stylesheets/main.875de78c.min.css">
      
        
        <link rel="stylesheet" href="../assets/stylesheets/palette.f1a3b89f.min.css">
        
          
          
          <meta name="theme-color" content="#2094f3">
        
      
    
    
    
      
        
        <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:300,400,400i,700%7CRoboto+Mono&display=fallback">
        <style>:root{--md-text-font-family:"Roboto";--md-code-font-family:"Roboto Mono"}</style>
      
    
    
    
    
      
    
    
  </head>
  
  
    
    
    
    
    
    <body dir="ltr" data-md-color-scheme="" data-md-color-primary="blue" data-md-color-accent="">
  
    
    <script>function __prefix(e){return new URL("..",location).pathname+"."+e}function __get(e,t=localStorage){return JSON.parse(t.getItem(__prefix(e)))}</script>
    
    <input class="md-toggle" data-md-toggle="drawer" type="checkbox" id="__drawer" autocomplete="off">
    <input class="md-toggle" data-md-toggle="search" type="checkbox" id="__search" autocomplete="off">
    <label class="md-overlay" for="__drawer"></label>
    <div data-md-component="skip">
      
        
        <a href="#enum-enum_ccdh_substance_substance_type" class="md-skip">
          Skip to content
        </a>
      
    </div>
    <div data-md-component="announce">
      
    </div>
    
      <header class="md-header" data-md-component="header">
  <nav class="md-header__inner md-grid" aria-label="Header">
    <a href=".." title="CRDC-H Model in LinkML documentation" class="md-header__button md-logo" aria-label="CRDC-H Model in LinkML documentation" data-md-component="logo">
      
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 8a3 3 0 0 0 3-3 3 3 0 0 0-3-3 3 3 0 0 0-3 3 3 3 0 0 0 3 3m0 3.54C9.64 9.35 6.5 8 3 8v11c3.5 0 6.64 1.35 9 3.54 2.36-2.19 5.5-3.54 9-3.54V8c-3.5 0-6.64 1.35-9 3.54z"/></svg>

    </a>
    <label class="md-header__button md-icon" for="__drawer">
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M3 6h18v2H3V6m0 5h18v2H3v-2m0 5h18v2H3v-2z"/></svg>
    </label>
    <div class="md-header__title" data-md-component="header-title">
      <div class="md-header__ellipsis">
        <div class="md-header__topic">
          <span class="md-ellipsis">
            CRDC-H Model in LinkML documentation
          </span>
        </div>
        <div class="md-header__topic" data-md-component="header-topic">
          <span class="md-ellipsis">
            
              Enum: enum_CCDH_Substance_substance_type
            
          </span>
        </div>
      </div>
    </div>
    
    
    
      <label class="md-header__button md-icon" for="__search">
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5z"/></svg>
      </label>
      
<div class="md-search" data-md-component="search" role="dialog">
  <label class="md-search__overlay" for="__search"></label>
  <div class="md-search__inner" role="search">
    <form class="md-search__form" name="search">
      <input type="text" class="md-search__input" name="query" aria-label="Search" placeholder="Search" autocapitalize="off" autocorrect="off" autocomplete="off" spellcheck="false" data-md-component="search-query" data-md-state="active" required>
      <label class="md-search__icon md-icon" for="__search">
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5z"/></svg>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11h12z"/></svg>
      </label>
      <button type="reset" class="md-search__icon md-icon" aria-label="Clear" tabindex="-1">
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M19 6.41 17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12 19 6.41z"/></svg>
      </button>
    </form>
    <div class="md-search__output">
      <div class="md-search__scrollwrap" data-md-scrollfix>
        <div class="md-search-result" data-md-component="search-result">
          <div class="md-search-result__meta">
            Initializing search
          </div>
          <ol class="md-search-result__list"></ol>
        </div>
      </div>
    </div>
  </div>
</div>
    
    
  </nav>
</header>
    
    <div class="md-container" data-md-component="container">
      
      
        
      
      <main class="md-main" data-md-component="main">
        <div class="md-main__inner md-grid">
          
            
              
              <div class="md-sidebar md-sidebar--primary" data-md-component="sidebar" data-md-type="navigation" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    


<nav class="md-nav md-nav--primary" aria-label="Navigation" data-md-level="0">
  <label class="md-nav__title" for="__drawer">
    <a href=".." title="CRDC-H Model in LinkML documentation" class="md-nav__button md-logo" aria-label="CRDC-H Model in LinkML documentation" data-md-component="logo">
      
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 8a3 3 0 0 0 3-3 3 3 0 0 0-3-3 3 3 0 0 0-3 3 3 3 0 0 0 3 3m0 3.54C9.64 9.35 6.5 8 3 8v11c3.5 0 6.64 1.35 9 3.54 2.36-2.19 5.5-3.54 9-3.54V8c-3.5 0-6.64 1.35-9 3.54z"/></svg>

    </a>
    CRDC-H Model in LinkML documentation
  </label>
  
  <ul class="md-nav__list" data-md-scrollfix>
    
      
      
      

  
  
  
    <li class="md-nav__item">
      <a href="../home/" class="md-nav__link">
        Home
      </a>
    </li>
  

    
      
      
      

  
  
  
    <li class="md-nav__item">
      <a href=".." class="md-nav__link">
        Index
      </a>
    </li>
  

    
      
      
      

  
  
  
    <li class="md-nav__item">
      <a href="../data-migration/" class="md-nav__link">
        Data Migration
      </a>
    </li>
  

    
      
      
      

  
  
  
    <li class="md-nav__item">
      <a href="../credits/" class="md-nav__link">
        Credits
      </a>
    </li>
  

    
  </ul>
</nav>
                  </div>
                </div>
              </div>
            
            
              
              <div class="md-sidebar md-sidebar--secondary" data-md-component="sidebar" data-md-type="toc" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    
<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
    
  
  
    <label class="md-nav__title" for="__toc">
      <span class="md-nav__icon md-icon"></span>
      Table of contents
    </label>
    <ul class="md-nav__list" data-md-component="toc" data-md-scrollfix>
      
        <li class="md-nav__item">
  <a href="#other-properties" class="md-nav__link">
    Other properties
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#permissible-values" class="md-nav__link">
    Permissible Values
  </a>
  
</li>
      
    </ul>
  
</nav>
                  </div>
                </div>
              </div>
            
          
          <div class="md-content" data-md-component="content">
            <article class="md-content__inner md-typeset">
              
                
                
                <h1 id="enum-enum_ccdh_substance_substance_type">Enum: enum_CCDH_Substance_substance_type</h1>
<p>Autogenerated Enumeration for CRDC-H Substance substance_type</p>
<p>URI: <a href="https://example.org/ccdh/enum_CCDH_Substance_substance_type">ccdh:enum_CCDH_Substance_substance_type</a></p>
<h2 id="other-properties">Other properties</h2>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Comments:</strong></td>
<td></td>
<td>Name according to TCCM: "CRDC-H.Substance.substance_type"</td>
</tr>
</tbody>
</table>
<h2 id="permissible-values">Permissible Values</h2>
<table>
<thead>
<tr>
<th align="left">Text</th>
<th align="center">Description</th>
<th align="center">Meaning</th>
<th align="right">Other Information</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">Anti-PTK7/Auristatin-0101 Antibody-drug Conjugate PF-06647020</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">EGFR/TGFb Fusion Monoclonal Antibody BCA101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Naphthalimide Analogue UNBS5162</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oral Ixabepilone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">DNA Minor Groove Binding Agent SG2000</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dromostanolone Propionate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pegylated Liposomal Nanoparticle-based Docetaxel Prodrug MNK-010</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ALK/FAK/Pyk2 Inhibitor CT-707</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Attenuated Measles Virus Encoding SCD Transgene TMV-018</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Zotatifin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bcl-2 Inhibitor BGB-11417</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rovalpituzumab Tesirine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Erastin Analogue PRLX 93936</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mitoflaxone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-EGFRvIII Antibody Drug Conjugate AMG 595</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Protein Arginine Methyltransferase 5 Inhibitor GSK3326595</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mcl-1 Inhibitor AZD5991</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pasireotide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-LAG-3 Monoclonal Antibody LAG525</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-C4.4a Antibody-Drug Conjugate BAY1129980</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Alofanib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Levothyroxine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Epipropidine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oblimersen Sodium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Navoximod</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-NY-ESO1/LAGE-1A TCR/scFv Anti-CD3 IMCnyeso</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Infliximab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Epothilone Analog UTD1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Indicine-N-Oxide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HER2-targeting Antibody Fc Fragment FS102</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">UAE Inhibitor TAK-243</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Toremifene</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HM2/MMAE Antibody-Drug Conjugate ALT-P7</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Onvatilimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tenalisib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-L1/4-1BB Bispecific Antibody INBRX-105</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Imaradenant</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">FGF Receptor Antagonist HGS1036</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PR1/HLA-A2 Monoclonal Antibody Hu8F4</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">DR5-targeting Tetrameric Nanobody Agonist TAS266</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nilotinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sobuzoxane</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Safingol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Onartuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Methotrexate Sodium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ipilimumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Hydroxychloroquine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Neoantigen-based Melanoma-Poly-ICLC Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Phytochlorin Sodium-Polyvinylpyrrolidone Complex</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Spongistatin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">TRPM8 Agonist D-3263</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Folate Receptor-Targeted Vinca Alkaloid/Mitomycin C EC0225</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Trifluridine and Tipiracil Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Anti-WT1 Immunotherapeutic GSK2302024A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cytokine-based Biologic Agent IRX-2</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-LIF Monoclonal Antibody MSC-1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-Ribonucleoprotein Antibody ATRC-101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PARP-1/2 Inhibitor ABT-767</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bemcentinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">2-Methoxyestradiol Nanocrystal Colloidal Dispersion</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Yttrium Y 90 DOTA Anti-CEA Monoclonal Antibody M5A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bis(choline)tetrathiomolybdate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">AXL/ FLT3/VEGFR2 Inhibitor KC1036</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Soy Protein Isolate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-LIV-1 Monoclonal Antibody-MMAE Conjugate SGN-LIV1A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ipafricept</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Doxorubicin-HPMA Conjugate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Allogeneic GM-CSF-secreting Breast Cancer Vaccine SV-BR-1-GM</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">p70S6K/Akt Inhibitor MSC2363318A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Acridine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">p97 Inhibitor CB-5339</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pan-KRAS Inhibitor BI 1701963</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Brentuximab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Zuclomiphene Citrate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Retelliptine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Zorubicin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Interferon</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lurtotecan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pirfenidone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Non-Small Cell Lung Cancer mRNA-Derived Vaccine CV9201</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Trans Sodium Crocetinate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Androgen Receptor Ligand-binding Domain-encoding Plasmid DNA Vaccine MVI-118</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PE/HPV16 E7/KDEL Fusion Protein/GPI-0100 TVGV-1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Androstane Steroid HE3235</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Antibody-drug Conjugate ABBV-085</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bicalutamide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Granulocyte-Macrophage Colony-Stimulating Factor</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">OPCs/Green Tea/Spirullina/Curcumin/Antrodia Camphorate/Fermented Soymilk Extract Capsule</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bortezomib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oxaliplatin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lipid Nanoparticle Encapsulated mRNAs Encoding Human IL-12A/IL-12B MEDI-1191</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ribonuclease QBI-139</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Detorubicin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Folate Receptor-Targeted Tubulysin Conjugate EC1456</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Alemtuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fas Ligand-treated Allogeneic Mobilized Peripheral Blood Cells</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bruceanol A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ispinesib Mesylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Buthionine Sulfoximine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pentoxifylline</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Fractalkine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">IDH1(R132) Inhibitor IDH305</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">XBP1-US/XBP1-SP/CD138/CS1 Multipeptide Vaccine PVX-410</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mezagitamab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-GARP Monoclonal Antibody ABBV-151</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tubercidin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dacarbazine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">NG-nitro-L-arginine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">FGFR2 Inhibitor RLY-4008</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Radotinib Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vascular Disrupting Agent BNC105P</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sustained-release Mitomycin C Hydrogel Formulation UGN-101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CXCR4 Monoclonal Antibody PF-06747143</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Iodine I-131</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">iPSC-derived Natural Killer Cells FT500</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HDAC8 Inhibitor NBM-BMX</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CLDN6 Monoclonal Antibody ASP1650</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Piroxantrone Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sizofiran</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Allogeneic Cellular Vaccine 1650-G</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fianlimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bcl-2 Inhibitor S65487</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oxidopamine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rhenium Re-186 Hydroxyethylidene Diphosphonate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">TRK Inhibitor AZD6918</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MCL-1 Inhibitor AMG 176</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Plitidepsin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tubulin-Binding Agent SSR97225</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD32B Monoclonal Antibody BI-1206</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Metatinib Tromethamine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oral Cancer Vaccine V3-OVA</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-IL-8 Monoclonal Antibody HuMax-IL8</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ingenol Mebutate Gel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Docetaxel Polymeric Micelles</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ametantrone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MEK inhibitor CS3006</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sunitinib Malate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous ROR2-targeted CAR T-cells CCT301-59</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cell Cycle Checkpoint/DNA Repair Antagonist IC83</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Enasidenib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nogapendekin Alfa</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Intetumumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Chiauranib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CAR T-Cells AMG 119</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fadrozole Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-L1 Monoclonal Antibody RC98</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Etirinotecan Pegol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Thalidomide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mafosfamide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Protein Phosphatase 2A Inhibitor LB-100</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Calaspargase Pegol-mknl</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Polypodium leucotomos Extract</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tegafur-Uracil</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">FAK Inhibitor VS-4718</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Acodazole</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Genistein</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BTK Inhibitor HZ-A-018</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">4'-Iodo-4'-Deoxydoxorubicin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sulofenur</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Paclitaxel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PARP Inhibitor E7016</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-L1/TIM-3 Bispecific Antibody LY3415244</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Afatinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Akt/ERK Inhibitor ONC201</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous NKG2D CAR-CD3zeta-DAP10-expressing T-Lymphocytes CYAD-01</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Checkpoint Kinase Inhibitor XL844</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous CD19/PD-1 Bispecific CAR-T Cells</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Long Peptide Vaccine 7</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Matrix Metalloproteinase Inhibitor MMI270</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tivantinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pinometostat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bleomycin Sulfate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">EGFR Inhibitor TY-9591</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Samuraciclib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD30 Monoclonal Antibody MDX-1401</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Survivin mRNA Antagonist EZN-3042</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ianalumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-VEGF Anticalin PRS-050-PEG40</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">LMB-2 Immunotoxin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Crenolanib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Verubulin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Chlorodihydropyrimidine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">St. John's Wort</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Brequinar Sodium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">mTOR Kinase Inhibitor PP242</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">2-Hydroxyestrone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Delanzomib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tomaralimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Total Androgen Blockade</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">FGFR/VEGFR/PDGFR/FLT3/SRC Inhibitor XL999</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cactinomycin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-1 Monoclonal Antibody AK105</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Talaporfin Sodium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PKC-beta Inhibitor MS-553</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Azathioprine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Genetically-modified MAGE-A4 C1032 T Cells</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Zinc Finger Nuclease ZFN-758</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Prednisolone Sodium Phosphate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MUC1-targeted Peptide GO-203-2C</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aminopterin Sodium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Serplulimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">2-Hydroxyestradiol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Plasmid DNA Vaccine pING-hHER3FL</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ang2/VEGF-Binding Peptides-Antibody Fusion Protein CVX-241</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-GRP78 Monoclonal Antibody PAT-SM6</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-LAG-3 Monoclonal Antibody IBI-110</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD123/CD3 Bispecific Antibody APVO436</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cimetidine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Synthetic hTERT DNA Vaccine INO-1401</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Infigratinib Mesylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cedazuridine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tilogotamab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-TROP2 Antibody-drug Conjugate BAT8003</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oxaliplatin-Encapsulated Transferrin-Conjugated N-glutaryl Phosphatidylethanolamine Liposome</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Anti-NY-ESO-1/LAGE-1 TCR-transduced c259 T Lymphocytes GSK3377794</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Spirogermanium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HSP90-targeted SN-38 Conjugate PEN-866</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Prednisolone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ras Peptide CYS</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">SHP2 Inhibitor RMC-4630</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Copper Cu 67 Tyr3-octreotate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Integrin alpha-2 Inhibitor E7820</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Survivin Antigen Vaccine DPX-Survivac</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Anti-CD22 CAR-4-1BB-TCRz-transduced T-lymphocytes CART22-65s</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ALK/TRK Inhibitor TSR-011</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PRL-3 Monoclonal Antibody PRL3-zumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tenifatecan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">FGFR Inhibitor TAS-120</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Siltuximab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Denintuzumab Mafodotin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PI3K-delta Inhibitor HMPL 689</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Topical Betulinic Acid</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Hsp90-targeted Photosensitizer HS-201</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pimasertib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Heparan Sulfate Glycosaminoglycan Mimetic M402</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Hsp90 Inhibitor AB-010</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD19 iCAR NK Cells</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Polyunsaturated Fatty Acid</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CAB-ROR2-ADC BA3021</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Levothyroxine Sodium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fenebrutinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Triptolide Analog</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Panobinostat Nanoparticle Formulation MTX110</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HLA-A2-restricted Melanoma-specific Peptides Vaccine GRN-1201</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-VEGF/ANG2 Nanobody BI 836880</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Iodine I 131 Derlotuximab Biotin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Digitoxin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rindopepimut</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nucleotide Analogue GS 9219</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD47 ADC SGN-CD47M</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Triptorelin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PSMA/CD3 Monoclonal Antibody MOR209/ES414</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ets-family Transcription Factor Inhibitor TK216</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Adenosine A2A/A2B Receptor Antagonist AB928</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-L1 Monoclonal Antibody TG-1501</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lintuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Roniciclib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pexmetinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ispinesib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dexamethason</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oral Hsp90 Inhibitor IPI-493</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monalizumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PVRIG Monoclonal Antibody COM701</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Selinexor</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Budigalimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">DHEA Mustard</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">SSTR2-targeting Protein/DM1 Conjugate PEN-221</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Annamycin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CEACAM1 Monoclonal Antibody CM-24</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Enavatuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ensituximab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-1 Monoclonal Antibody BAT1306</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Raf Kinase Inhibitor HM95573</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Emapalumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Canfosfamide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-L1 Monoclonal Antibody MDX-1105</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Palonosetron Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Gemcitabine-Releasing Intravesical System</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Allogeneic Anti-CD20-CAR T-cells PBCAR20A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Yttrium Y 90 Colloid</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Colchicine-Site Binding Agent ABT-751</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Antineoplastic Agent Combination SM-88</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pan-AKT Inhibitor ARQ751</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Zalutumumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Filanesib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">White Carrot</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Marizomib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HPV 16 E7 Antigen-expressing Lactobacillis casei Vaccine BLS-ILB-E710c</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-HER2/Anti-CD3 Bispecific Monoclonal Antibody BTRC 4017A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lutetium Lu 177-DTPA-omburtamab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bufalin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cladribine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Azimexon</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Imetelstat Sodium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pan-PIM Inhibitor INCB053914</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Liposomal Curcumin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cyclodextrin-Based Polymer-Camptothecin CRLX101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Streptozocin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-BCMA/CD3 BiTE Antibody AMG 701</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-MUC16/CD3 BiTE Antibody REGN4018</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oltipraz</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tetrahydrouridine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Telratolimod</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Amuvatinib Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sodium Salicylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sirolimus</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-TIM3 Monoclonal Antibody SHR-1702</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">DEC-205/NY-ESO-1 Fusion Protein CDX-1401</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Methanol Extraction Residue of BCG</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aminoflavone Prodrug AFP464</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous BCMA-targeted CAR T Cells CC-98633</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Icrucumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Prostate Cancer Antigen-expressing Dendritic Cell Vaccine BPX-101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Engineered Human Umbilical Vein Endothelial Cells AB-205</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ifabotuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sodium Phenylbutyrate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">FGFR Inhibitor Debio 1347</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pyrotinib Dimaleate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CD40 Agonist Monoclonal Antibody CP-870,893</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Alpha-Thioguanine Deoxyriboside</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bispecific Antibody 2B1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rocapuldencel-T</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">NLRP3 Agonist BMS-986299</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-alpha5beta1 Integrin Antibody MINT1526A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD33 Antibody-drug Conjugate IMGN779</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Glofitamab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD20 Monoclonal Antibody MIL62</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-FGFR2 Antibody BAY1179470</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-TIM-3 Monoclonal Antibody INCAGN02390</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tasisulam</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Firtecan Pegol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bafetinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BRAF(V600E) Kinase Inhibitor ABM-1310</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Urabrelimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Puquitinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Salmonella VNP20009</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Hyaluronidase-zzxf/Pertuzumab/Trastuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Belotecan Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BET Inhibitor CPI-0610</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Camptothecin-20(S)-O-Propionate Hydrate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Colloidal Gold-Bound Tumor Necrosis Factor</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mitomycin B</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-DR5 Agonist Monoclonal Antibody TRA-8</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sabarubicin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Navarixin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Parsaclisib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ulocuplumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Yttrium Y 90 Tabituximab Barzuxetan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CTLA-4 Monoclonal Antibody BCD-145</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Iodine I 131 MIP-1095</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Roflumilast</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Multipeptide Vaccine S-588210</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Selonsertib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Adenoviral Tumor-specific Neoantigen Priming Vaccine GRT-C901</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD3/Anti-BCMA Bispecific Monoclonal Antibody JNJ-64007957</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Chlorambucil</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Teclistamab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Green Tea Extract-based Antioxidant Supplement</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">IDO1/TDO2 Inhibitor DN1406131</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-EphA2 Antibody-directed Liposomal Docetaxel Prodrug MM-310</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PDK1 Inhibitor AR-12</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Topical Gemcitabine Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Methotrexate-Encapsulating Autologous Tumor-Derived Microparticles</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pioglitazone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rigosertib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Zalcitabine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Shenqi Fuzheng Injection SQ001</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Chlorotoxin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Selective Estrogen Receptor Degrader LX-039</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Chk1 Inhibitor GDC-0575</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bexmarilimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lutetium Lu-177 Girentuximab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Coenzyme Q10</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ChiNing Decoction</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Darleukin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Immediate-release Tablet Afuresertib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pelareorep</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-GD2 Monoclonal Antibody MORAb-028</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Banoxantrone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Holmium Ho 166 Poly(L-Lactic Acid) Microspheres</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing CD4+/CD8+ T-lymphocytes JCARH125</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Luminespib Mesylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sacituzumab Govitecan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Kanglaite</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PLK1 Inhibitor CYC140</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Gastrin Immunotoxin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-B7-H3 Antibody DS-5573a</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">mTOR Kinase Inhibitor OSI-027</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Beta-Glucan MM-10-001</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Therapeutic Estradiol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Interleukin-15/Interleukin-15 Receptor Alpha Complex-Fc Fusion Protein XmAb24306</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tasisulam Sodium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Eniluracil/5-FU Combination Tablet</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Botanical Agent LEAC-102</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Androgen Receptor Antagonist TAS3681</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lontucirev</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lipid Encapsulated Anti-PLK1 siRNA TKM-PLK1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Exatecan Mesylate Anhydrous</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Samalizumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Betulinic Acid</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CD11b Agonist GB1275</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Apomine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ROBO1-targeted BiCAR-NKT Cells</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Attenuated Listeria monocytogenes CRS-100</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Saracatinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-ICOS Monoclonal Antibody MEDI-570</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">10-Deacetyltaxol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tasquinimod</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Gemcitabine Hydrochloride Emulsion</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Belinostat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Methylselenocysteine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Selective Estrogen Receptor Modulator TAS-108</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-ACTR/4-1BB/CD3zeta-Viral Vector-transduced Autologous T-Lymphocytes ACTR087</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Taxol Analogue SID 530</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tisotumab Vedotin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Y 90 Monoclonal Antibody M195</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">SERD G1T48</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tositumomab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PARP Inhibitor NMS-03305293</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Serdemetan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Niraparib Tosylate Monohydrate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Maraba Oncolytic Virus Expressing Mutant HPV E6/E7</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Silicon Phthalocyanine 4</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tipifarnib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">pan-PI3K/mTOR Inhibitor SF1126</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cortisone Acetate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tarenflurbil</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Venetoclax</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Melphalan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Src Kinase Inhibitor M475271</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">TLR8 Agonist DN1508052</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Gemcitabine Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Carbon C 14-pamiparib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">GSK-3 Inhibitor 9-ING-41</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Methylprednisolone Acetate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-HER2-DM1 Antibody-drug Conjugate GQ1001</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Genetically Modified Interleukin-12 Transgene-encoding Bifidobacterium longum</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Darolutamide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Zanolimumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ganitumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vedolizumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PCNU</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Brentuximab Vedotin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Elagolix</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">EGFR Antisense DNA BB-401</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Synthetic hTERT DNA Vaccine INO-1400</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Black Cohosh</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vinfosiltine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aprutumab Ixadotin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Personalized Neoantigen DNA Vaccine GNOS-PVO2</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-FLT3 Monoclonal Antibody IMC-EB10</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Doxifluridine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CTLA-4 Monoclonal Antibody HBM4003</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mifamurtide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Leurubicin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Diarylsulfonylurea Compound ILX-295501</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cordycepin Triphosphate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Selective Human Estrogen-receptor Alpha Partial Agonist TTC-352</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tesevatinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-OX40 Monoclonal Antibody IBI101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tavokinogene Telseplasmid</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Asparaginase Erwinia chrysanthemi</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HPV E6/E7-encoding Arenavirus Vaccine HB-201</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Beta-Thioguanine Deoxyriboside</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">AXL Inhibitor DS-1205c</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Hsp90 Inhibitor BIIB028</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Clivatuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Iodine I 131 Tositumomab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aziridinylbenzoquinone RH1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Hycanthone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lutetium Lu 177 Lilotomab-satetraxetan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Epirubicin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Trimetrexate Glucuronate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Antimetabolite FF-10502</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody HuAFP31</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dual IGF-1R/InsR Inhibitor BMS-754807</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Budotitane</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Synthetic Alkaloid PM00104</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-TIM-3 Monoclonal Antibody MBG453</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">7-Cyanoquinocarcinol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous CD19 CAR-expressing CD4+/CD8+ T-cells MB-CART19.1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fluoxymesterone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Revdofilimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Capecitabine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vorinostat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BTK Inhibitor LOXO-305</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Annamycin Liposomal</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pseudoisocytidine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dactinomycin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Seneca Valley Virus-001</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD20-engineered Toxin Body MT-3724</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">GBM Antigens and Alloantigens Immunotherapeutic Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nanoparticle-based Paclitaxel Suspension</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Puromycin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rodorubicin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Yttrium Y 90-DOTA-Biotin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Adenoviral Transduced hIL-12-expressing Autologous Dendritic Cells INXN-3001 Plus Activator Ligand INXN-1001</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pralatrexate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Metformin Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Erdafitinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD27 Agonistic Monoclonal Antibody MK-5890</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Copanlisib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Teprotumumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Spherical Nucleic Acid Nanoparticle NU-0129</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Prinomastat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">SN-38-Loaded Polymeric Micelles NK012</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">IMT-1012 Immunotherapeutic Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vulinacimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">TP40 Immunotoxin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">TGF-beta Receptor 1 Kinase Inhibitor SH3051</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-L1 Monoclonal Antibody A167</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Radgocitabine Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-HER2 Monoclonal Antibody B002</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Zandelisib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ofranergene Obadenovec</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Liposomal Docetaxel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CSF1R Monoclonal Antibody IMC-CS4</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Peptichemio</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Trigriluzole</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">LV.IL-2/B7.1-Transduced AML Blast Vaccine RFUSIN2-AML1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Docetaxel-PNP</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Radgocitabine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MET Tyrosine Kinase Inhibitor SAR125844</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">LMP7 Inhibitor M3258</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ionomycin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fisogatinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vincristine Sulfate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Triethylenemelamine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Yttrium Y 90-Edotreotide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CK2-targeting Synthetic Peptide CIGB-300</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-1/CTLA-4 Bispecific Antibody AK104</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Spiromustine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ivosidenib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ALK Inhibitor RO5424802</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MDM2 Inhibitor AMGMDS3</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mivebresib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Peripheral Blood Lymphocytes from Ibrutinib-treated Chronic Lymphocytic Leukemia Patients IOV-2001</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PRIMA-1 Analog APR-246</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BTK Inhibitor DTRMWXHS-12</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Daratumumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">GS/pan-Notch Inhibitor AL101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody 105AD7 Anti-idiotype Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-c-Met Monoclonal Antibody HLX55</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Combretastatin A1 Diphosphate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD70 CAR-expressing T Lymphocytes</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">NTRK/ROS1 Inhibitor DS-6051b</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vibecotamab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nemorubicin Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Paricalcitol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mosedipimod</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mesothelin/CD3e Tri-specific T-cell Activating Construct HPN536</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cyclophosphamide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Muscadine Grape Extract</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Acolbifene Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Asaley</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Multi-glioblastoma-peptide-targeting Autologous Dendritic Cell Vaccine ICT-107</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Synthetic Hypericin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Toll-like Receptor 7 Agonist DSP-0509</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nortopixantrone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">pan-PIM Kinase Inhibitor NVP-LGB-321</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dihydro-5-Azacytidine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Atorvastatin Calcium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Immunomodulator OHR/AVR118</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-HIF-1alpha LNA Antisense Oligonucleotide EZN-2968</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mirzotamab Clezutoclax</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bevacizumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PI3K Inhibitor BGT226</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Irinotecan Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Luminespib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tucotuzumab Celmoleukin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MARCKS Protein Inhibitor BIO-11006</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Perflenapent Emulsion</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-prolactin Receptor Antibody LFA102</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pibrozelesin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">9-Ethyl 6-Mercaptopurine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CDK Inhibitor R547</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cathelicidin LL-37</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">VEGF Inhibitor PTC299</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Polo-like Kinase 1 Inhibitor NMS-1286937</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BCMA-CD19 Compound CAR T Cells</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-1 Monoclonal Antibody JTX-4014</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Leucovorin Calcium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-BCMA Antibody-drug Conjugate AMG 224</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Forodesine Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bispecific Antibody AGEN1223</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-1 Monoclonal Antibody Sym021</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-VEGFR3 Monoclonal Antibody IMC-3C5</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Arginine Butyrate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">pNGVL4a-CRT-E6E7L2 DNA Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-BCMA Antibody SEA-BCMA</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Leucovorin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">SLC6A8 Inhibitor RGX-202</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-Met Monoclonal Antibody Mixture Sym015</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Paclitaxel PPE Microspheres</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Elesclomol Sodium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pibenzimol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cereblon Modulator CC-90009</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">EGFR Inhibitor DBPR112</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD47 Monoclonal Antibody SRF231</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Modotuximab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Etoglucid</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Iodine I 131 Rituximab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lometrexol Sodium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Teloxantrone Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Human Papillomavirus 16 E7 Peptide/Padre 965.10</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Trebananib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bendamustine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Zibotentan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">NY-ESO-B</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tagraxofusp-erzs</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Omipalisib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dinutuximab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Immunomodulatory Oligonucleotide HYB2055</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Live-attenuated Listeria monocytogenes-encoding EGFRvIII-NY-ESO-1 Vaccine ADU-623</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Taxane Compound</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Squalamine Lactate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Citarinostat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cytarabine-asparagine Prodrug BST-236</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Triaziquone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tubulin Binding Agent TTI-237</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD157 Monoclonal Antibody MEN1112</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Camptothecin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD33/CD3 Bispecific Antibody GEM 333</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Galiximab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Carbetimer</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CEA-targeting Agent RG6123</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Iniparib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MOv-gamma Chimeric Receptor Gene</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Realgar-Indigo naturalis Formulation</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fosbretabulin Disodium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sodium-Potassium Adenosine Triphosphatase Inhibitor RX108</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tamrintamab Pamozirine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vadacabtagene Leraleucel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD47 Monoclonal Antibody IMC-002</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Efatutazone Dihydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Talampanel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rubitecan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Gedatolisib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD33 Antigen/CD3 Receptor Bispecific Monoclonal Antibody AMV564</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Matuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MET Kinase Inhibitor OMO-1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody CC49-delta CH2</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PSMA/PBD ADC MEDI3726</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">N-dihydrogalactochitosan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">FPV Vaccine CV301</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sialyl Tn-KLH Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-TGF-beta Monoclonal Antibody SAR-439459</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sipuleucel-T</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">LSD1 Inhibitor RO7051790</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD47 Monoclonal Antibody IBI188</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PSA/PSMA DNA Plasmid INO-5150</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cixutumumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">hTERT Vaccine V934/V935</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Atiprimod</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oxaliplatin Eluting Beads</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-ICOS Agonist Antibody GSK3359609</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Belvarafenib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Allogeneic CD8+ Leukemia-associated Antigens Specific T Cells NEXI-001</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CD80-Fc Fusion Protein ALPN-202</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody GD2 Anti-Idiotype Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">dUTPase/DPD Inhibitor TAS-114</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Interferon Alfacon-1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Duvortuxizumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dimethylmyleran</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Antiangiogenic Drug Combination TL-118</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cationic Liposome-Encapsulated Paclitaxel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Actinomycin C3</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Methionine Aminopeptidase 2 Inhibitor PPI-2458</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-1 Monoclonal Antibody BCD-100</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ICT-121 Dendritic Cell Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Obatoclax Mesylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PGG Beta-Glucan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ibandronate Sodium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Degarelix</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PI3K Inhibitor ZSTK474</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Alitretinoin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Prohibitin-Targeting Peptide 1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Namodenoson</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pan-TRK Inhibitor ONO-7579</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nimesulide-Hyaluronic Acid Conjugate CA102N</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-HIV-1 Lentiviral Vector-expressing sh5/C46 Cal-1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD3/Anti-GPRC5D Bispecific Monoclonal Antibody JNJ-64407564</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Interleukin-12</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Jin Fu Kang</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cord Blood-derived Expanded Natural Killer Cells PNK-007</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fluvastatin Sodium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD123 Monoclonal Antibody CSL360</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Fas Ligand</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Morpholinodoxorubicin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Irofulven</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Therapeutic Breast/Ovarian/Prostate Peptide Cancer Vaccine DPX-0907</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Axicabtagene Ciloleucel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Tyrosinase-Related Protein-2</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Artemisinin Dimer</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">DPT/Typhoid/Staphylococcus aureus/Paratyphoid A/Paratyphoid B Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mutant-selective EGFR Inhibitor PF-06459988</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Famitinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Abarelix</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Milademetan Tosylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Light-activated AU-011</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fazarabine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">iPSC-derived CD16-expressing Natural Killer Cells FT516</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Selective Cytokine Inhibitory Drug CC-1088</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Clodronic Acid</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lutetium Lu 177 DOTA-biotin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Batabulin Sodium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Compound Kushen Injection</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ontorpacept</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous FRa-4SCAR-expressing T-cells 4SCAR-FRa</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Talimogene Laherparepvec</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Topotecan Sustained-release Episcleral Plaque</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">mRNA-based Personalized Cancer Vaccine mRNA-4157</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CD123-CD33 Compound CAR T Cells</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">mTOR Inhibitor GDC-0349</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Itraconazole</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Polyethylene Glycol Recombinant Endostatin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Idiotype-Pulsed Autologous Dendritic Cell Vaccine APC8020</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Camptothecin Analogue TLC388</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Picrasinoside H</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Maytansine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Beta-lapachone Prodrug ARQ 761</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">TRPV6 Calcium Channel Inhibitor SOR-C13</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD38 Monoclonal Antibody SAR442085</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">VEGFR2 Tyrosine Kinase Inhibitor PF-00337210</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Treosulfan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ragifilimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Spartalizumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">13-Deoxydoxorubicin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PLK1 Inhibitor TAK-960</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Bone Marrow-derived CD34/CXCR4-positive Stem Cells AMR-001</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bcl-2 Inhibitor BCL201</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oral Azacitidine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pepinemab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Andrographolide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fedratinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Yttrium Y 90 Anti-CEA Monoclonal Antibody cT84.66</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Amifostine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mobocertinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Perfosfamide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">RSK1-4 Inhibitor PMD-026</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-BCMA/PBD ADC MEDI2228</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Upifitamab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-FGFR4 Monoclonal Antibody U3-1784</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody RAV12</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BTK Inhibitor CT-1530</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-fucosyl-GM1 Monoclonal Antibody BMS-986012</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Padeliporfin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cancell</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oxidative Phosphorylation Inhibitor IACS-010759</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ERK Inhibitor MK-8353</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Milataxel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cemiplimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">IGF-methotrexate Conjugate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">NEDD8 Activating Enzyme E1 Inhibitor TAS4464</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Naptumomab Estafenatox</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cabiralizumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">hTERT-encoding DNA Vaccine INVAC-1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody R24</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PRMT5 Inhibitor PRT811</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CEA BiTE Monoclonal Antibody AMG211</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Liposomal Mitoxantrone Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">RhoC Peptide Vaccine RV001V</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CD44v6-specific CAR T-cells</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Geranylgeranyltransferase I Inhibitor</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">SERD SAR439859</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Chlorozotocin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Allogeneic Anti-CD19-CAR T-cells PBCAR0191</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pan-FLT3/Pan-BTK Multi-kinase Inhibitor CG-806</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pegylated SN-38 Conjugate PLX038</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pegaspargase</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous AFP Specific T Cell Receptor Transduced T Cells C-TCR055</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Zotiraciclib Citrate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pegylated Recombinant L-asparaginase Erwinia chrysanthemi</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Taurolidine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ningetinib Tosylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Seviteronel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fluorouracil</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dociparstat sodium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Amrubicin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Methylprednisolone Sodium Succinate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Scopoletin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Paclitaxel Liposome</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Varlitinib Tosylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HDAC Inhibitor AR-42</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Neratinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BH3 Mimetic ABT-737</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Remetinostat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Atrasentan Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cisplatin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Phenethyl Isothiocyanate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Anti-CD19 TAC-T cells TAC01-CD19</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-C-met Monoclonal Antibody SAIT301</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Acai Berry Juice</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CpG Oligodeoxynucleotide GNKG168</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tyrosinase Peptide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Trastuzumab-TLR 7/8 Agonist BDC-1001</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Liposomal NDDP</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Interferon Beta</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CDK7 Inhibitor CT7001</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">RAF Kinase Inhibitor L-779450</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Microbiome GEN-001</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Triptorelin Pamoate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">L-Gossypol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sodium Dichloroacetate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Adenosine A2A Receptor Antagonist AZD4635</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Gossypol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Syk Inhibitor HMPL-523</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Verpasep Caltespen</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous TCR-engineered T-cells IMA203</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Curcumin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Resiquimod Topical Gel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Membrane-Disrupting Peptide EP-100</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rituximab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ciltacabtagene Autoleucel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tyrosine Kinase Inhibitor XL228</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-BCMA/CD3 BiTE Antibody AMG 420</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Yttrium Y-90 Ibritumomab Tiuxetan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Hsp90 Inhibitor TQB3474</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Domatinostat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Hsp90 Inhibitor MPC-3100</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Albumin-binding Cisplatin Prodrug BTP-114</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">EBNA-1 inhibitor VK-2019</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pictilisib Bismesylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Porfimer Sodium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Motesanib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD137 Agonistic Monoclonal Antibody CTX-471</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">STING-activating Cyclic Dinucleotide Agonist MIW815</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Androgen Receptor Inhibitor EPI-7386</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bisthianostat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Perillyl Alcohol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Neratinib Maleate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Prolgolimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">mTOR1/2 Kinase Inhibitor ME-344</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CD20-CD19 Compound CAR T Cells</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PARP 1/2 Inhibitor IMP4297</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Halichondrin B</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Amino Acid Injection</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Iodine I 131 Monoclonal Antibody 81C6</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Gamboge Resin Extract TSB-9-W1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Topical Trichloroacetic Acid</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CDK7 Inhibitor SY-5609</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Litronesib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">SIRPa-Fc Fusion Protein TTI-621</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Hemiasterlin Analog E7974</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Liothyronine Sodium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ralaniten Acetate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-IGF-1R Recombinant Monoclonal Antibody BIIB022</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-HER2 Bi-specific Monoclonal Antibody ZW25</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Antibody-drug Conjugate ABBV-838</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Limonene, (+/-)-</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bcl-Xs Adenovirus Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Hsp90 Inhibitor HSP990</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pharmacological Ascorbate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Zinostatin Stimalamer</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing Memory T-lymphocytes bb21217</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Paxalisib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">GM-CSF-encoding Oncolytic Adenovirus CGTG-102</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Doxorubicin Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">p53-HDM2 Interaction Inhibitor MI-773</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PRAME T-cell Receptor/Anti-CD3 scFv Fusion Protein IMC-F106C</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Levetiracetam</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ARC Fusion Protein SL-279252</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Larotinib Mesylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD40 Agonist Monoclonal Antibody CDX-1140</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MEK Inhibitor RO4987655</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cenisertib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-5T4 Antibody-Drug Conjugate PF-06263507</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nucleotide Analog Prodrug NUC-3373</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">NY-ESO-1-specific TCR Gene-transduced T Lymphocytes TBI-1301</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Phellodendron amurense Bark Extract</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-GPR20/DXd Antibody-drug Conjugate DS-6157a</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody ASP1948</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ieramilimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-EGFR Monoclonal Antibody SYN004</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tezacitabine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Carmustine in Ethanol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Androgen Receptor Antisense Oligonucleotide EZN-4176</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nitric Oxide-Releasing Acetylsalicylic Acid Derivative</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Actinomycin C2</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PSMA-targeted Docetaxel Nanoparticles BIND-014</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Warfarin Sodium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">XIAP Antisense Oligonucleotide AEG35156</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Numidargistat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Medroxyprogesterone Acetate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BXQ-350 Nanovesicle Formulation</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Limonene, (+)-</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Telatinib Mesylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lerociclib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lanreotide Acetate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bispecific Antibody AMG 509</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Wnt-5a Mimic Hexapeptide Foxy-5</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Anti-CD19/CD20 Bispecific Nanobody-based CAR-T cells</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Individualized MVA-based Vaccine TG4050</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-1/Anti-CTLA4 DART Protein MGD019</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Deuteporfin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Etoricoxib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cevipabulin Fumarate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sodium Stibogluconate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sorafenib Tosylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bruceanol H</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Uroacitides</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Human Monoclonal Antibody B11-hCG Beta Fusion Protein CDX-1307</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cemadotin Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-VISTA Monoclonal Antibody JNJ 61610588</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">N-Methylformamide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Danusertib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Clioquinol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Arcitumomab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Trimethylcolchicinic Acid</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Abagovomab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody AbGn-7</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HDAC6 Inhibitor KA2507</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PARP Inhibitor CEP-9722</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Hodgkin's Antigens-GM-CSF-Expressing Cell Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tocotrienol-rich Fraction</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lyophilized Black Raspberry Lozenge</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pilaralisib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anetumab Ravtansine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Alpelisib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Demecolcine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Piposulfan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oncolytic Newcastle Disease Virus MTH-68H</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-1 Monoclonal Antibody HX008</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Larotrectinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Porcupine Inhibitor XNW7201</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PI3K/mTOR Kinase Inhibitor DS-7423</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Allogeneic Natural Killer Cell Line MG4101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">huBC1-huIL12 Fusion Protein AS1409</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD3/Anti-CD20 Trifunctional Bispecific Monoclonal Antibody FBTA05</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-latent TGF-beta 1 Monoclonal Antibody SRK-181</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Retinol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cedazuridine/Azacitidine Combination Agent ASTX030</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lipid Nanoparticle Encapsulating Glutathione S-transferase P siRNA NBF-006</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pladienolide Derivative E7107</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Antineoplaston AS2-1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nidanilimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody m170</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HSP90alpha/beta Inhibitor TAS-116</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">SHP-1 Agonist SC-43</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BTK Inhibitor ARQ 531</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Asparaginase</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ethinyl Estradiol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Extended Release Flucytosine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nifurtimox</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tocotrienol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-OX40 Antibody BMS 986178</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Flutamide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Etanercept</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Monocyte-derived Lysate-pulsed Dendritic Cell Vaccine PV-001-DC</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Imetelstat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MET Tyrosine Kinase Inhibitor EMD 1204831</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-1 Checkpoint Inhibitor PF-06801591</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aphidicoline Glycinate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ascrinvacumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">IL-2 Recombinant Fusion Protein ALT-801</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vinblastine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Obinutuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Anti-HLA-A*02/AFP TCRm-expressing T-cells ET140202</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Interleukin-15 Fusion Protein BJ-001</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Quinine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Retifanlimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ritrosulfan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Avelumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Trimelamol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">FLT3/ABL/Aurora Kinase Inhibitor KW-2449</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MAGE-A3 Multipeptide Vaccine GL-0817</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PD-1 Directed Probody CX-188</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fludarabine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Apalutamide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Gemcitabine-Phosphoramidate Hydrochloride NUC-1031</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Etoposide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Epratuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PI3K/mTOR Kinase Inhibitor VS-5584</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Canfosfamide Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Imalumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fms/Trk Tyrosine Kinase Inhibitor PLX7486 Tosylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dexrazoxane</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CYP17/CYP11B2 Inhibitor LAE001</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cositecan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Blinatumomab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Idarubicin-Eluting Beads</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Picibanil</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-TGF-beta Monoclonal Antibody NIS793</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ubidecarenone Nanodispersion BPM31510n</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Melphalan Hydrochloride/Sulfobutyl Ether Beta-Cyclodextrin Complex</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Smac Mimetic LCL161</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tarextumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Allogeneic GM-CSF-secreting Lethally Irradiated Whole Melanoma Cell Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CD123-specific Targeting Module TM123</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Macitentan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tazarotene</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ortataxel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BP-Cx1-Platinum Complex BP-C1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous TCR-engineered T-cells IMA201</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-HER2 Monoclonal Antibody CT-P6</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tomato-Soy Juice</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Samarium Sm 153-DOTMP</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Natural IFN-alpha OPC-18</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Interleukin-15 Agonist Fusion Protein SHR1501</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Smoothened Antagonist BMS-833923</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Durvalumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Intoplicine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Anti-CD19 Chimeric Antigen Receptor T-cells AUTO1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CD44 Targeted Agent SPL-108</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cyclopentenyl Cytosine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rigosertib Sodium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">7-Ethyl-10-Hydroxycamptothecin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bacillus Calmette-Guerin Substrain Connaught Live Antigen</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Taxane Analogue TPI 287</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pegylated Deoxycytidine Analogue DFP-14927</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Elesclomol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lilotomab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Huaier Extract Granule</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aurora A Kinase/Tyrosine Kinase Inhibitor ENMD-2076</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Taurultam</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fedratinib Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tocilizumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pegvorhyaluronidase Alfa</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-OX40 Hexavalent Agonist Antibody INBRX-106</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Birabresib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tributyrin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dihydroorotate Dehydrogenase Inhibitor BAY2402234</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ondansetron Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fursultiamine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-BTLA Monoclonal Antibody TAB004</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BMS-184476</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ruthenium Ru-106</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Polidocanol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Deuterated Enzalutamide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PRAME Immunotherapeutic GSK2302032A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Macrophage Colony-Stimulating Factor</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HER-2-positive B-cell Peptide Antigen P467-DT-CRM197/Montanide Vaccine IMU-131</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Metoprine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Iodine I 125-Anti-EGFR-425 Monoclonal Antibody</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Carmustine Sustained-Release Implant Wafer</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-EGFR TAP Antibody-drug Conjugate IMGN289</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Brimonidine Tartrate Nanoemulsion OCU-300</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ontuxizumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Trabectedin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Auranofin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Saracatinib Difumarate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">INO-1001</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Src/tubulin Inhibitor KX02</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Moxetumomab Pasudotox</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Anti-CD20 CAR Transduced CD4/CD8 Enriched T-cells MB-CART20.1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bermekimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Broad-Spectrum Human Papillomavirus Vaccine V505</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bushen-Jianpi Decoction</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Eftilagimod Alpha</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PSMA/CD3 Tri-specific T-cell Activating Construct HPN424</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Omacetaxine Mepesuccinate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Enoticumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-L1 Monoclonal Antibody HLX20</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BET inhibitor BI 894999</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Synthetic Long E6/E7 Peptides Vaccine HPV-01</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous MAGE-A3/A6-specific TCR Gene-engineered Lymphocytes KITE-718</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bempegaldesleukin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Zalifrelimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Pancreatic Adenocarcinoma Lysate and mRNA-loaded Dendritic Cell Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CHP-NY-ESO-1 Peptide Vaccine IMF-001</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vonlerolizumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD3/CD7-Ricin Toxin A Immunotoxin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PI3K Inhibitor GDC0077</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Avdoralimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-NaPi2b Monoclonal Antibody XMT-1535</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Resistant Starch</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Polyvalent Melanoma Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Efatutazone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD37 Monoclonal Antibody BI 836826</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Platinum</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Babaodan Capsule</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD46 Antibody-drug Conjugate FOR46</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anastrozole</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Trilaciclib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">FGFR4 Antagonist INCB062079</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CDK4/6 Inhibitor TQB3616</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Roblitinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-MUC16/CD3 Bispecific Antibody REGN4018</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Berubicin Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Prednisolone Acetate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aurora Kinase Inhibitor SNS-314</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Alsevalimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fresolimumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">At 211 Monoclonal Antibody 81C6</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sargramostim</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">AE37 Peptide/GM-CSF Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD19 Monoclonal Antibody MDX-1342</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Microbial EDP1503</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vorolanib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Iodine I 131 IPA</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bavituximab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-BTN3A Agonistic Monoclonal Antibody ICT01</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Antibody-drug Conjugate SC-002</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CDK2/5/9 Inhibitor CYC065</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nirogacestat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">SarCNU</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Multi-epitope Anti-folate Receptor Peptide Vaccine TPIV 200</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Glutaminase Inhibitor IPN60090</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HER2 Inhibitor CP-724,714</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Indole-3-Carbinol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cordycepin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Diethylnorspermine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Survivin Antigen</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BET Bromodomain Inhibitor ZEN-3694</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Navy Bean Powder</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ceramide Nanoliposome</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sacubitril/Valsartan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ERa36 Modulator Icaritin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Belagenpumatucel-L</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cyclin-dependent Kinase 8/19 Inhibitor BCD 115</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cinobufotalin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-HER-2 Bispecific Antibody KN026</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">mRNA-based TriMix Melanoma Vaccine ECI-006</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Linperlisib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD40/Anti-TAA Bispecific Monoclonal Antibody ABBV-428</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Elpamotide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">SIRPa-IgG4-Fc Fusion Protein TTI-622</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ERK1/2 Inhibitor HH2710</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Exatecan Mesylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MUC-1/WT1 Peptide-primed Autologous Dendritic Cells</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">FLT3 Inhibitor FF-10101 Succinate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ATR Kinase Inhibitor VX-803</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">DNA-PK inhibitor AZD7648</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pegdinetanib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">AKR1C3-activated Prodrug OBI-3424</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tetanus Toxoid Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sonidegib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-EGFR/HER2/HER3 Monoclonal Antibody Mixture Sym013</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PARP7 Inhibitor RBN-2397</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rhenium Re-188 Etidronate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-ErbB3 Antibody ISU104</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Inecalcitol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Methylprednisolone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oleandrin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PEG-interleukin-2</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Simeprevir</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tepoditamab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oligonucleotide SPC2996</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Gossypol Acetic Acid</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Emibetuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">pNGVL4a-Sig/E7(detox)/HSP70 DNA and HPV16 L2/E6/E7 Fusion Protein TA-CIN Vaccine PVX-2</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HPV Types 16/18 E6/E7-Adenoviral Transduced Autologous Lymphocytes/alpha-Galactosylceramide Vaccine BVAC-C</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HDAC Inhibitor OBP-801</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dibrospidium Chloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Atamestane</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Calcium Release-activated Channels Inhibitor RP4010</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody MX35 F(ab')2</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nab-paclitaxel/Rituximab-coated Nanoparticle AR160</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Estradiol Valerate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ashwagandha Root Powder Extract</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cerdulatinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Digoxin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">p97 Inhibitor CB-5339 Tosylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mucoadhesive Paclitaxel Formulation</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-L1 Monoclonal Antibody CK-301</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tubulin Inhibitor ALB-109564</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PI3K Alpha/mTOR Inhibitor PWT33597 Mesylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-NY-ESO-1 Immunotherapeutic GSK-2241658A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD123 Monoclonal Antibody KHK2823</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Smac Mimetic GDC-0917</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mivobulin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lovastatin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Repotrectinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Human Papillomavirus Bivalent Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Volasertib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">VEGFR-2 DNA Vaccine VXM01</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Immediate-release Onapristone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-MAGE-A4 T-cell Receptor/Anti-CD3 scFv Fusion Protein IMC-C103C</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lumretuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD47 Monoclonal Antibody SHR-1603</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Adenoviral Brachyury Vaccine ETBX-051</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Antibody-drug Conjugate MEDI7247</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Daclizumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Palifosfamide Tromethamine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sodium Iodide I-131</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">FGFR4 Inhibitor BLU 9931</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rucaparib Camsylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD45 Monoclonal Antibody AHN-12</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Imidazole-Pyrazole</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Radium Ra 224-labeled Calcium Carbonate Microparticles</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BL22 Immunotoxin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MEK Inhibitor PD0325901</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Alpha V Beta 1 Inhibitor ATN-161</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-c-Met Antibody-drug Conjugate HTI-1066</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tabelecleucel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">2,6-Diaminopurine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Azaserine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Futibatinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Atezolizumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">VGEFR/c-kit/PDGFR Tyrosine Kinase Inhibitor XL820</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-nectin-4 Monoclonal Antibody-Drug Conjugate AGS-22M6E</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Unknown</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">EGFR Mutant-selective  Inhibitor TQB3804</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Anti-CD19 CAR-CD3zeta-4-1BB-expressing T-cells PZ01</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Shared Anti-Idiotype-AB-S006</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Anti-FLT3 CAR T Cells AMG 553</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-Denatured Collagen Monoclonal Antibody TRC093</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Human Adenovirus Type 5 H101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Allogeneic Anti-BCMA-CAR T-cells PBCAR269A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Andecaliximab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aurora A Kinase Inhibitor TAS-119</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Teloxantrone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Girodazole</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Milatuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant MIP1-alpha Variant ECI301</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Personalized Cancer Vaccine RO7198457</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vatalanib Succinate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD20 Monoclonal Antibody BAT4306F</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-BCMA/Anti-CD3 Bispecific Antibody REGN5459</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Botanical Agent BEL-X-HG</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tegavivint</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bispecific Antibody MDX447</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-OX40 Agonist Monoclonal Antibody PF-04518600</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Zinostatin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD98 Monoclonal Antibody IGN523</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Romidepsin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pan-TRK Inhibitor NOV1601</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-mesothelin/MMAE Antibody-Drug Conjugate DMOT4039A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Microtubule Inhibitor SCB01A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ropocamptide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">2-Fluoroadenine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">c-Met Inhibitor AMG 337</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-VEGF Monoclonal Antibody hPV19</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Galarubicin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Thioredoxin-1 Inhibitor PX-12</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rucaparib Phosphate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dabrafenib Mesylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Adenosine A2A Receptor Antagonist NIR178</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CLEC12A/CD3 Bispecific Antibody MCLA117</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">c-Met Inhibitor JNJ-38877605</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Glioblastoma Multiforme Multipeptide Vaccine IMA950</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Clanfenur</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Allogeneic CD56-positive CD3-negative Natural Killer Cells CYNK-001</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ranibizumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Custirsen Sodium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oraxol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Amonafide L-Malate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tasidotin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-L1 Monoclonal Antibody ZKAB001</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Capivasertib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous CD38-4SCAR-expressing T-cells 4SCAR38</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Eflornithine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aurora A Kinase Inhibitor LY3295668 Erbumine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Figitumumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD37 Antibody-Drug Conjugate IMGN529</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Agonistic Anti-OX40 Monoclonal Antibody INCAGN01949</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Zoledronic Acid</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dual-affinity B7-H3/CD3-targeted Protein MGD009</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">DKK1-Neutralizing Monoclonal Antibody DKN-01</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CXCR4 Antagonist BL-8040</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Conditionally Active Biologic Anti-AXL Antibody-drug Conjugate BA3011</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">STING Agonist SB 11285</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Immunotoxin CMD-193</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vapreotide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Irinotecan/P-glycoprotein Inhibitor HM30181AK Combination Tablet</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vilaprisan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Camptothecin Glycoconjugate BAY 38-3441</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CDK4/6 Inhibitor CS3002</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Peginterferon Alfa-2a</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Polysaccharide-K</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Idelalisib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Interleukin-2 Liposome</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tamoxifen Citrate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-EGFR Monoclonal Antibody CPGJ 602</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-IL-8 Monoclonal Antibody BMS-986253</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dubermatinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PI3K Inhibitor ACP-319</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Carmustine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HER2 ECD+TM Virus-like Replicon Particles Vaccine AVX901</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-EGFR/DM1 Antibody-drug Conjugate AVID100</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mercaptopurine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lometrexol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rilimogene Galvacirepvec/Rilimogene Glafolivec</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Thyroid Extract</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fruquintinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sasanlimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-TAG-72 Monoclonal Antibody scFV CC-49/218</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Abemaciclib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CEACAM6 Antibody BAY1834942</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Antibody-drug Conjugate ABBV-011</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">EGFR T790M Antagonist BPI-15086</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lavendustin A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">GSK-3 Inhibitor LY2090314</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">mTORC1/2 Kinase Inhibitor BI 860585</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tirbanibulin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Triazene Derivative CB10-277</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Telaglenastat Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Triamcinolone Hexacetonide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lobaplatin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Shark Cartilage</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tauromustine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vascular Disrupting Agent ZD6126</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tesetaxel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CSF1R Inhibitor DCC-3014</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mureletecan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Penclomedine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cinrebafusp Alfa</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Palifosfamide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">STAT3 Inhibitor OPB-51602</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ralimetinib Mesylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MKC-1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Paclitaxel Polymeric Micelle Formulation NANT-008</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Immunocytokine NHS-IL2-LT</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Coxsackievirus V937</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Brequinar</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">SHP2 Inhibitor TNO155</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Margetuximab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">I 131 Monoclonal Antibody F19</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-VEGFC Monoclonal Antibody VGX-100</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-HER3 Antibody-drug Conjugate U3 1402</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Methoxyamine Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pentostatin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Quadrivalent Human Papillomavirus (types 6, 11, 16, 18) Recombinant Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">EGFR Antagonist Hemay022</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Modified Vaccinia Ankara-vectored HPV16/18 Vaccine JNJ-65195208</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Baricitinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Xevinapant</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Anti-EGFR CAR-transduced CXCR 5-modified T-lymphocytes</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BET Inhibitor GSK2820151</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Anti-PSMA CAR-T Cells P-PSMA-101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous CD22-4SCAR-expressing T-cells 4SCAR22</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Phosphaplatin PT-112</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous LMP1/LMP2/EBNA1-specific HLA-A02:01/24:02/11:01-restricted TCR-expressing T-lymphocytes YT-E001</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">DNMT1 Inhibitor NTX-301</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Angiogenesis Inhibitor JI-101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">L-methylfolate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mutant IDH1 Inhibitor DS-1001</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Multikinase Inhibitor 4SC-203</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Enadenotucirev</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">LMP-2:419-427 Peptide Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">FGFR1/2/3 Inhibitor HMPL-453</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Gataparsen Sodium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Erwinia asparaginase JZP-458</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Alefacept</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MetAP2 Inhibitor APL-1202</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tinostamustine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Irradiated Allogeneic Human Lung Cancer Cells Expressing OX40L-Ig Vaccine HS-130</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Elgemtumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pipobroman</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Laromustine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Savolitinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Antibody-drug Conjugate SC-007</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bozitinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ansamitomicin P-3</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MET Tyrosine Kinase Inhibitor BMS-777607</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Axl/Mer Inhibitor PF-07265807</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Huang Lian</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ATR Inhibitor RP-3500</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pyroxamide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Peptide 946-Tetanus Peptide Conjugate Melanoma Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tamoxifen</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tezacitabine Anhydrous</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Daratumumab and Hyaluronidase-fihj</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cediranib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">cis-Urocanic Acid</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sabatolimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Porfiromycin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lodapolimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tubulin Inhibitor ALB 109564 Dihydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">TIGIT-targeting Agent MK-7684</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cintirorgon</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD40 Monoclonal Antibody Chi Lob 7/4</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lyso-Thermosensitive Liposome Doxorubicin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Asunercept</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">OxPhos Inhibitor VLX600</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Chaparrin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD20 Monoclonal Antibody TL011</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Daniquidone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">DNA-dependent Protein Kinase Inhibitor VX-984</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Troriluzole</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MK0731</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dostarlimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Liposomal Vinorelbine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Toripalimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tretazicar</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vector-peptide Conjugated Paclitaxel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Penberol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PVA Microporous Hydrospheres/Doxorubicin Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pyrotinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">8-Azaguanine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MAT2A Inhibitor AG-270</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cofetuzumab Pelidotin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HCV DNA Vaccine INO-8000</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PI3K-delta Inhibitor YY-20394</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Amustaline</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vinzolidine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Valrubicin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">A2A Receptor Antagonist EOS100850</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aprutumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Renal Cell Carcinoma Peptides Vaccine IMA901</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Genetically-modified MAGE-A4 C1032 CD8alpha T Cells</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Protein Kinase C Inhibitor IDE196</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Androgen Receptor Antagonist SHR3680</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cabozantinib S-malate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bruceanol F</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CTLA-4 Monoclonal Antibody REGN4659</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Super-compound Interferon</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Esorubicin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Topoisomerase I Inhibitor LMP776</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Brigatinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fenretinide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Denibulin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tigapotide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Adavosertib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oncolytic Measles Virus Encoding Helicobacter pylori Neutrophil-activating Protein</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Galocitabine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Hu14.18-IL2 Fusion Protein EMD 273063</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-HER2/MMAE Antibody-drug Conjugate MRG002</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pamidronic Acid</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Antibody-drug Conjugate SC-005</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-TF Monoclonal Antibody ALT-836</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mitoguazone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nanoscale Coordination Polymer Nanoparticles CPI-100</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Epitinib Succinate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Folate Receptor-Targeted Vinca Alkaloid EC0489</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Febuxostat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CHK1 Inhibitor PF-477736</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">TGFbeta Inhibitor LY3200882</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Imidazole Mustard</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Hsp90 Inhibitor SNX-5422 Mesylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bosutinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Allogeneic Melanoma Vaccine AGI-101H</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Phosphorus P-32</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Magnesium Valproate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vaccinium myrtillus/Macleaya cordata/Echinacea angustifolia Extract Granules</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oncolytic HSV-1 Expressing IL-12 and Anti-PD-1 Antibody T3011</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Inotuzumab Ozogamicin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Azintuxizumab Vedotin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lutetium Lu 177 Dotatate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Anti-CD19 T-cell Receptor T cells ET190L1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD73 Monoclonal Antibody CPI-006</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-1/Anti-PD-L1 Bispecific Antibody LY3434172</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">EGFR/HER2 Inhibitor AP32788</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">SR-BP1/HSI Inhibitor SR31747A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-LGR5 Monoclonal Antibody BNC101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mixed Bacteria Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Methotrexate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cyproterone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ancitabine Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">siG12D LODER</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Attenuated Live Listeria Encoding HPV 16 E7 Vaccine ADXS11-001</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Elmustine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fludarabine Phosphate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Prostate Cancer Vaccine ONY-P1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Opolimogene Capmilisbac</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MALT1 Inhibitor JNJ-67856633</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">S1P Receptor Agonist KRP203</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nicotinamide Riboside</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Peptide 946 Melanoma Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">DNA Plasmid-encoding Interleukin-12 INO-9012/PSA/PSMA DNA Plasmids INO-5150 Formulation INO-5151</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Chimeric Monoclonal Antibody 81C6</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pan-Mutant-IDH1 Inhibitor Bay-1436032</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Entinostat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Methotrexate-E Therapeutic Implant</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Danvatirsen</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cetuximab-loaded Ethylcellulose Polymeric Nanoparticles Decorated with Octreotide (SY)</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">FAP/4-1BB-targeting Fusion Protein RO7122290</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CDK Inhibitor SNS-032</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-LAG3 Monoclonal Antibody MK-4280</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">EGFR Mutant-specific Inhibitor CK-101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">EZH1/2 Inhibitor HH2853</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ripretinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CYP17/Androgen Receptor Inhibitor ODM 204</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">FGFR4 Inhibitor H3B-6527</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ERK Inhibitor LTT462</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PI3K-gamma Inhibitor IPI-549</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody CAL</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-MUC17/CD3 BiTE Antibody AMG 199</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PI3K Inhibitor GSK1059615</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ethylnitrosourea</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Acridine Carboxamide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pemigatinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ulixertinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Glesatinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Anti-CD19 CAR T-cells 19(T2)28z1xx</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dilpacimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Epcoritamab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aryl Hydrocarbon Receptor Inhibitor IK-175</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-L1 Monoclonal Antibody SHR-1316</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Carubicin Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Antrodia cinnamomea Supplement</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">TRK Inhibitor TQB3558</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Oncolytic Poliovirus PVS-RIPO</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dopamine-Somatostatin Chimeric Molecule BIM-23A760</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sparfosate Sodium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BR96-Doxorubicin Immunoconjugate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Raloxifene</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Prostaglandin E2 EP4 Receptor Inhibitor AN0025</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-FCRH5/CD3 BiTE Antibody BFCR4350A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Edotecarin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HDAC inhibitor CG200745</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vocimagene Amiretrorepvec</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">SNS01-T Nanoparticles</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Immunoconjugate RO5479599</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CTLA-4/LAG-3 Bispecific Antibody XmAb22841</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Zorifertinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">TLR Agonist BSG-001</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Enfortumab Vedotin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Acalisib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PI3K Inhibitor WX-037</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ziv-Aflibercept</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-EGFR/c-Met Bispecific Antibody JNJ-61186372</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Porcupine Inhibitor WNT974</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Antigen-presenting Cells-expressing HPV16 E6/E7 SQZ-PBMC-HPV</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Phospholipid Ether-drug Conjugate CLR 131</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Beta-elemene</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Glutathione Pegylated Liposomal Doxorubicin Hydrochloride Formulation 2B3-101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD38 Antibody-drug Conjugate STI-6129</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tesidolumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Amuvatinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Echinomycin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Liposome-encapsulated OSI-7904</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cold Contaminant-free Iobenguane I-131</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">I 131 Monoclonal Antibody A33</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Beta-Glucan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">STING Agonist BMS-986301</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Relacorilant</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">NA17.A2 Peptide Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Allogeneic CD22-specific Universal CAR-expressing T-lymphocytes UCART22</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Alpha-tocopheryloxyacetic Acid</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous TCRm-expressing T-cells ET140203</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Enadenotucirev-expressing Anti-CD40 Agonistic Monoclonal Antibody NG-350A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Multikinase Inhibitor AT9283</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-Glypican 3/CD3 Bispecific Antibody ERY974</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-1/Anti-LAG-3 DART Protein MGD013</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Antisense Oligonucleotide GTI-2040</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PH20 Hyaluronidase-expressing Adenovirus VCN-01</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD3 Immunotoxin A-dmDT390-bisFv(UCHT1)</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-1 Monoclonal Antibody TSR-042</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-APRIL Monoclonal Antibody BION-1301</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Gusperimus Trihydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Blueberry Powder Supplement</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody 4B5 Anti-Idiotype Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Epipodophyllotoxin Analog GL331</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-Ganglioside GM2 Monoclonal Antibody BIW-8962</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Simalikalactone D</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cobomarsen</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mitotane</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Quarfloxin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Glasdegib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pegylated Liposomal Mitomycin C Lipid-based Prodrug</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">VEGFR Inhibitor KRN951</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">SERD ZN-c5</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Submicron Particle Paclitaxel Sterile Suspension</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Taurultam Analogue GP-2250</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">IDH1 Mutant Inhibitor LY3410738</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Clarithromycin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD44 Monoclonal Antibody RO5429083</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Metformin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Topical Fluorouracil</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">N-(5-tert-butyl-3-isoxazolyl)-N-(4-(4-pyridinyl)oxyphenyl) Urea</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pegylated Liposomal Irinotecan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CCR7 Antibody-drug Conjugate JBH492</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nemorubicin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-HGF Monoclonal Antibody TAK-701</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anhydrous Enol-oxaloacetate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Yttrium Y 90 Resin Microspheres</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Telaglenastat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Racotumomab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tallimustine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tetrathiomolybdate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lurtotecan Liposome</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CEA/Anti-HSG Bispecific Monoclonal Antibody TF2</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Y 90 Monoclonal Antibody Lym-1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Xiliertinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-HER2-DM1 ADC B003</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">JAK2 Inhibitor XL019</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Trastuzumab/Tesirine Antibody-drug Conjugate ADCT-502</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anthramycin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Peplomycin Sulfate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fluorine F 18 Ara-G</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nivolumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fotretamine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD38-targeted IgG4-attenuated IFNa TAK-573</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Topoisomerase-II-beta Inhibitor Racemic XK469</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Hedgehog Inhibitor IPI-609</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Doxorubicin Prodrug/Prodrug-activating Biomaterial SQ3370</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Brachyury-expressing Yeast Vaccine GI-6301</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pan-IDH Mutant Inhibitor AG-881</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mechlorethamine Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Belapectin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Olaratumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MDM2/MDMX Inhibitor ALRN-6924</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Terameprocol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-5T4 Antibody-drug Conjugate SYD1875</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Talabostat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">DACH Polymer Platinate AP5346</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bersanlimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">STING-expressing E. coli SYNB1891</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Depatuxizumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous HPV16 E7-specific HLA-A*02:01-restricted TCR Gene Engineered Lymphocytes KITE-439</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Coltuximab Ravtansine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">RET/SRC Inhibitor TPX-0046</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Triciribine Phosphate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Berzosertib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Microparticle-encapsulated CYP1B1-encoding DNA Vaccine ZYC300</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ipatasertib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Selitrectinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Flumatinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Etalocib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Bispecific CD19/CD22-targeted CAR-T Cells GC022</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mitoxantrone Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Altretamine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tucidinostat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cetrelimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody A27.15</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">I 131 Monoclonal Antibody Lym-1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ursolic Acid</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dianhydrogalactitol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oncolytic HSV-1 rQNestin34.5v.2</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Palladium Pd-103</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-L1/CD137 Bispecific Antibody MCLA-145</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-Lewis B/Lewis Y Monoclonal Antibody GNX102</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Iodine I 131 Monoclonal Antibody BC8</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Palbociclib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Radix Angelicae Sinensis/Radix Astragali Herbal Supplement</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">LMP-2:340-349 Peptide Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Varlitinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-A33 Monoclonal Antibody KRN330</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PEG-PEI-cholesterol Lipopolymer-encased IL-12 DNA Plasmid Vector GEN-1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sitimagene Ceradenovec</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-1 Monoclonal Antibody LZM009</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nanatinostat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Carmustine Implant</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Allovectin-7</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Telomerase Inhibitor FJ5002</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Human 6Ckine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Temoporfin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Camsirubicin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Topotecan Hydrochloride Liposomes</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cryptophycin 52</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Phenytoin Sodium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-ROR1/PNU-159682 Derivative Antibody-drug Conjugate NBE-002</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Enterococcus gallinarum Strain MRx0518</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Farletuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lapatinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Bacterial Minicells VAX014</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Umbralisib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">VEGFR/PDGFR Tyrosine Kinase Inhibitor TAK-593</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dovitinib Lactate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">I 131 Antiferritin Immunoglobulin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bromocriptine Mesylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ezabenlimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vaccine-Sensitized Draining Lymph Node Cells</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CDK4/6 Inhibitor SHR6390</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">EGFR Mutant-specific Inhibitor D-0316</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody TRK-950</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Notch Signaling Pathway Inhibitor MK0752</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD40 Agonist Monoclonal Antibody ABBV-927</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Momelotinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vinorelbine Tartrate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">p53-HDM2 Protein-protein Interaction Inhibitor APG-115</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lutetium Lu 177 Anti-CA19-9 Monoclonal Antibody 5B1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">EGFR/HER2 Inhibitor DZD9008</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bivalent BRD4 Inhibitor AZD5153</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ficlatuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BRAF/EGFR Inhibitor BGB-283</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Methylcantharidimide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fostriecin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PRMT1 Inhibitor GSK3368715</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sotrastaurin Acetate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vincristine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Celecoxib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Kunecatechins Ointment</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD33 Monoclonal Antibody-DM4 Conjugate AVE9633</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Black Raspberry Nectar</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Plamotamab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oncolytic HSV-1 G207</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">IDO1 Inhibitor MK-7162</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Short Chain Fatty Acid HQK-1004</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Imipramine Blue</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tislelizumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rucaparib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">cEt KRAS Antisense Oligonucleotide AZD4785</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cereblon E3 Ubiquitin Ligase Modulating Agent CC-99282</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-HER2 Monoclonal Antibody/Anti-CD137Anticalin Bispecific Fusion Protein PRS-343</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pevonedistat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Glioblastoma Cancer Vaccine ERC1671</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pacmilimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">DPX-E7 HPV Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Losoxantrone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Liarozole Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pembrolizumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ancitabine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CLEVER-1 Monoclonal Antibody FP-1305</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pemetrexed Disodium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bardoxolone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Alpha Galactosylceramide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Esperamicin A1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Axitinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">3'-dA Phosphoramidate NUC-7738</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Gemtuzumab Ozogamicin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sodium Butyrate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">P-cadherin Inhibitor PCA062</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pol I Inhibitor CX5461</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pirarubicin Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mps1 Inhibitor BAY 1217389</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Glioma-associated Peptide-loaded Dendritic Cell Vaccine SL-701</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Methionine Aminopeptidase 2 Inhibitor M8891</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PSA/IL-2/GM-CSF Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-HB-EGF Monoclonal Antibody KHK2866</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-c-MET Monoclonal Antibody LY2875358</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nimustine Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Interferon Alfa-N3</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Batabulin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HDAC Inhibitor CHR-2845</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-ILT4 Monoclonal Antibody MK-4830</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vitamin E Compound</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">VLP-encapsulated TLR9 Agonist CMP-001</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Milk Thistle</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Imexon</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Glycooptimized Trastuzumab-GEX</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Veltuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Denileukin Diftitox</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Onalespib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ribosome-Inactivating Protein CY503</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BC-819 Plasmid/Polyethylenimine Complex</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD74 Antibody-drug Conjugate STRO-001</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HIF-2alpha Inhibitor PT2977</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody Lym-1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Docetaxel Lipid Microspheres</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Listeria monocytogenes-LLO-PSA Vaccine ADXS31-142</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Liposome</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Panobinostat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Macrocycle-bridged STING Agonist E7766</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Belimumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Smac Mimetic GDC-0152</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mitomycin C Analog KW-2149</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Topical Celecoxib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cedazuridine/Decitabine Combination Agent ASTX727</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nilotinib Hydrochloride Monohydrate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-ICOS Monoclonal Antibody KY1044</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ivuxolimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Benaxibine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Yangzheng Xiaoji Extract</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">TLR7 agonist BNT411</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Zoptarelin Doxorubicin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bazedoxifene</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Selatinib Ditosilate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Colorectal Tumor-Associated Peptides Vaccine IMA910</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">KRAS G12C Inhibitor LY3499446</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bcl-2 Inhibitor LP-108</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PSMA Monoclonal Antibody-MMAE Conjugate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tirapazamine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HPV 16 E6/E7-encoding Arenavirus Vaccine HB-202</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ulinastatin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Formestane</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fosbretabulin Tromethamine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Hypoxia-activated Prodrug TH-4000</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD47 Monoclonal Antibody Hu5F9-G4</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oncolytic Virus RP1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-DKK-1 Monoclonal Antibody LY2812176</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ruxolitinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Amsacrine Lactate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Epratuzumab-cys-tesirine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Gold Sodium Thiomalate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Hsp90 Antagonist KW-2478</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Flt3/MerTK Inhibitor MRX-2843</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mannosylerythritol Lipid</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lacutamab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pralsetinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-L1 Monoclonal Antibody MSB2311</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oncolytic HSV-1 rRp450</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Thorium Th 227 Anti-PSMA Monoclonal Antibody BAY 2315497</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Simotaxel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Satraplatin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ubenimex</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BCMA/CD3e Tri-specific T-cell Activating Construct HPN217</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pegylated Liposomal Mitoxantrone Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Thioguanine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tafasitamab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Olvimulogene Nanivacirepvec</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">pan-RAF Kinase Inhibitor CCT3833</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mapatumumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sintilimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Virulizin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CEA-MUC-1-TRICOM Vaccine CV301</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Clomesone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ATR Kinase Inhibitor M6620</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-mesothelin Antibody-drug Conjugate BMS-986148</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD3/Anti-5T4 Bispecific Antibody GEN1044</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ranimustine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aspacytarabine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BCG Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Upamostat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Yttrium Y 90 Monoclonal Antibody B3</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-TIGIT Monoclonal Antibody AB154</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-IRF4 Antisense Oligonucleotide ION251</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">JAK Inhibitor INCB047986</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dioscorea nipponica Makino Extract DNE3</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HER2-targeted Liposomal Doxorubicin Hydrochloride MM-302</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Hsp90 Inhibitor SNX-5542 Mesylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dinaciclib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Liposomal Cytarabine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ruxotemitide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lutetium Lu 177-DOTA-EB-TATE</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-LAG-3 Monoclonal Antibody INCAGN02385</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD123-Pyrrolobenzodiazepine Dimer Antibody Drug Conjugate SGN-CD123A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-HER2-vc0101 ADC PF-06804103</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ganglioside GM2</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lorvotuzumab Mertansine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Filgrastim</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Phenethyl Isothiocyanate-containing Watercress Juice</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">EZH2 Inhibitor SHR2554</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Methyl-5-Aminolevulinate Hydrochloride Cream</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Immunotherapeutic Combination Product CMB305</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-1/CD47 Infusion Protein HX009</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-Met/EGFR Monoclonal Antibody LY3164530</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Menin-MLL Interaction Inhibitor SNDX-5613</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Crizotinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Benzaldehyde Dimethane Sulfonate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MAGE-A3-specific Immunotherapeutic GSK 2132231A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Thiarabine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-DLL4 Monoclonal Antibody MEDI0639</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-HER2/Anti-HER3 Bispecific Monoclonal Antibody MCLA-128</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nutraceutical TBL-12</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tipiracil</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oral Myoma Vaccine V3-myoma</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tepotinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tiomolibdate Diammonium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Retaspimycin Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-SIRPa Monoclonal Antibody CC-95251</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PI3K/BET Inhibitor LY294002</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Agatolimod Sodium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Combretastatin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-1 Fusion Protein AMP-224</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">NY-ESO-1/GLA-SE Vaccine ID-G305</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">IL-12-expressing HSV-1 NSC 733972</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Angiogenesis/Heparanase Inhibitor PG545</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Intiquinatine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Puquitinib Mesylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BET Inhibitor CC-90010</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Threonine Tyrosine Kinase Inhibitor CFI-402257</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Anti-CD19 Chimeric Antigen Receptor T-cells SJCAR19</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous ACTR-CD16-CD28-expressing T-lymphocytes ACTR707</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vemurafenib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pasotuxizumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rhenium Re 188 BMEDA-labeled Liposomes</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nanocell-encapsulated miR-16-based microRNA Mimic</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Interferon Beta-1A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fas Receptor Agonist APO010</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Superagonist Interleukin-15:Interleukin-15 Receptor alphaSu/Fc Fusion Complex ALT-803</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lactoferrin-derived Lytic Peptide LTX-315</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CD4-specific Telomerase Peptide Vaccine UCPVax</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-FLT3 Antibody-drug Conjugate AGS62P1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Etaracizumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lorlatinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Denosumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Panulisib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lomustine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Riviciclib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HLA-A*2402-Restricted Multipeptide Vaccine S-488410</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Chk1 Inhibitor CCT245737</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Hydroxyurea</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Halichondrin Analogue E7130</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Human MHC Non-Restricted Cytotoxic T-Cell Line TALL-104</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Smoothened Antagonist LEQ506</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Clomiphene Citrate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">5-Aza-4'-thio-2'-deoxycytidine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cevipabulin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Thyrotropin Alfa</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-FGFR3 Antibody-drug Conjugate LY3076226</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pegylated Recombinant Human Hyaluronidase PH20</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oncolytic Herpes Simplex Virus-1 ONCR-177</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pomegranate Juice</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Indisulam</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aceglatone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-HBEGF Monoclonal Antibody U3-1565</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD47 Monoclonal Antibody AO-176</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tolebrutinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CXCR1/2 Inhibitor SX-682</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous CD19-targeted CAR-T Cells GC007F</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dezaguanine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ropeginterferon Alfa-2B</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mibefradil</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Larotrectinib Sulfate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CHK1 Inhibitor MK-8776</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">DNA Interference Oligonucleotide PNT2258</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aryl Hydrocarbon Receptor Antagonist BAY2416964</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Alvocidib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Carmofur</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Beta Alethine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">STAT3 Inhibitor TTI-101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-mesothelin/MMAE Antibody-drug Conjugate RC88</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Atorvastatin Sodium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Talotrexin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Polyamine Analogue SBP-101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">TLR7 Agonist LHC165</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oprozomib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dactolisib Tosylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Avadomide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Decitabine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Yiqi-yangyin-jiedu Herbal Decoction</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MELK Inhibitor OTS167</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Hormone Therapy</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Edrecolomab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-1/CTLA-4 Bispecific Antibody MEDI5752</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BRAFV600/PI3K Inhibitor ASN003</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mifepristone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Conatumumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fibromun</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ciclopirox Prodrug CPX-POM</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Peginterferon Alfa-2b</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ladirubicin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD47 Monoclonal Antibody CC-90002</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mesna</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ipomeanol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">EED Inhibitor MAK683</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">EZH2 Inhibitor PF-06821497</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">mTORC 1/2 Inhibitor LXI-15029</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Gastrin/cholecystokinin Type B Receptor Inhibitor Z-360</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Leukocyte Interleukin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Taletrectinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Wnt Signaling Inhibitor SM04755</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-FAP/Interleukin-2 Fusion Protein RO6874281</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Clinical Trial</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Amustaline Dihydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Burosumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-L1 Monoclonal Antibody FAZ053</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sagopilone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Anti-BCMA-CAR Expressing Stem Memory T-cells P-BCMA-101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Encelimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MEK Inhibitor TAK-733</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Macimorelin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Imgatuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Multi-epitope HER2 Peptide Vaccine H2NVAC</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">IAP Inhibitor HGS1029</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Testolactone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cediranib Maleate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Folitixorin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sapitinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Alpha-lactalbumin-derived Synthetic Peptide-lipid Complex Alpha1H</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Androgen Receptor Antagonist TRC253</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD3/Anti-BCMA Bispecific Monoclonal Antibody PF-06863135</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Gamma-Secretase Inhibitor LY3039478</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tropomyosin Receptor Kinase Inhibitor AZD7451</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lutetium Lu 177 PP-F11N</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Personalized and Adjusted Neoantigen Peptide Vaccine PANDA-VAC</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD228/MMAE Antibody-drug Conjugate SGN-CD228A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Phosphorodiamidate Morpholino Oligomer AVI-4126</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">EP4 Antagonist ONO-4578</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HER2 Inhibitor DZD1516</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Yttrium Y 90 Anti-CDH3 Monoclonal Antibody FF-21101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Captopril</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tacedinaline</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Eg5 Kinesin-Related Motor Protein Inhibitor 4SC-205</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BRAF Inhibitor</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-Tissue Factor Monoclonal Antibody MORAb-066</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Orvacabtagene Autoleucel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aldesleukin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Givinostat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Selumetinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">O-Chloroacetylcarbamoylfumagillol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CD73 Inhibitor AB680</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lutetium Lu 177 DOTA-Tetulomab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Liposome-encapsulated TAAs mRNA Vaccine W_ova1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">LSD1 Inhibitor GSK2879552</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD38 Monoclonal Antibody TAK-079</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Afuresertib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Modakafusp Alfa</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Melphalan Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Entospletinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vandetanib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pegylated Interferon Alfa</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-DR5 Agonistic Monoclonal Antibody INBRX-109</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Selective Androgen Receptor Modulator RAD140</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Hsp90 Inhibitor DS-2248</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">LAIR-2 Fusion Protein NC410</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Interleukin Therapy</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PSCA Monoclonal Antibody AGS-1C4D4</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD73 Monoclonal Antibody TJ4309</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Anti-CD19 CAR T-cells IM19</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">2-Methoxyestrone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lentinan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Enasidenib Mesylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Yang Yin Fu Zheng</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tetraphenyl Chlorin Disulfonate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tilarginine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">11D10 AluGel Anti-Idiotype Monoclonal Antibody</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Duligotuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Docetaxel Nanoparticle CPC634</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Burixafor</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CXCR4 Inhibitor Q-122</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Checkpoint Kinase Inhibitor AZD7762</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Boanmycin Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD48/MMAE Antibody-drug Conjugate SGN-CD48A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tabalumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">c-Met Inhibitor MSC2156119J</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">TGFa-PE38 Immunotoxin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lenalidomide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Globo H-DT Vaccine OBI-833</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ecromeximab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Indocyanine Green-labeled Polymeric Micelles ONM-100</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Elinafide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Y 90 Monoclonal Antibody CC49</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Human Papillomavirus 11-valent Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-ROR1 ADC VLS-101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Asulacrine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bryostatin 1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-L1 Monoclonal Antibody GR1405</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Chrysanthemum morifolium/Ganoderma lucidum/Glycyrrhiza glabra/Isatis indigotica/Panax pseudoginseng/Rabdosia rubescens/Scutellaria baicalensis/Serona repens Supplement</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">SR-T100 Gel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Taminadenant</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tankyrase Inhibitor STP1002</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BET Inhibitor GS-5829</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cisplatin Liposomal</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">KRAS-MAPK Signaling Pathway Inhibitor JAB-3312</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Roquinimex</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Girentuximab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">TrkA Inhibitor VMD-928</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ERK1/2 Inhibitor LY3214996</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vinflunine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Alectinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Xiaoai Jiedu Decoction</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Erlotinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Menatetrenone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Phosphoramide Mustard</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Napabucasin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant CD40-Ligand</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rituximab Conjugate CON-4619</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mipsagargin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CCR2/CCR5 Antagonist BMS-813160</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bardoxolone Methyl</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Troxacitabine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Amivantamab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MEK 1/2 Inhibitor AS703988/MSC2015103B</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Concentrated Lingzhi Mushroom Extract</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-VEGFR2 Monoclonal Antibody MSB0254</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Androgen Receptor Downregulator AZD3514</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PEG-Proline-Interferon Alfa-2b</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Veliparib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Idecabtagene Vicleucel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD20 Monoclonal Antibody SCT400</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pyruvate Kinase Inhibitor TLN-232</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">LSD1 Inhibitor SYHA1807</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Partially Engineered T-regulatory Cell Donor Graft TRGFT-201</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">P-p68 Inhibitor RX-5902</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ERK1/2 Inhibitor ASN007</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CYP11A1 inhibitor ODM-208</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fosbretabulin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-OX40 Agonist Monoclonal Antibody BGB-A445</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Heparin Derivative SST0001</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous NKG2D CAR T-cells CYAD-02</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Terfluranol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Iodine I 131 Monoclonal Antibody F16SIP</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Inalimarev</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Prostatic Acid Phosphatase-Sargramostim Fusion Protein PA2024</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Maackia amurensis Seed Lectin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cobolimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">IDO1 Inhibitor KHK2455</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Anti-BCMA CAR T-cells PHE885</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BTK Inhibitor M7583</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Trastuzumab/Hyaluronidase-oysk</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nilutamide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mitoxantrone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Peposertib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CYL-02 Plasmid DNA</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pixatimod</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HPV6/11-targeted DNA Plasmid Vaccine INO-3107</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous CAR-mbIL15-Safety Switch T-cells PRGN-3006</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Trastuzumab Monomethyl Auristatin F</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Telapristone Acetate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Urelumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD1/CTLA4 Bispecific Antibody XmAb20717</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Melapuldencel-T</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Akt Inhibitor LY2780301</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vismodegib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ERK1/2 Inhibitor JSI-1187</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-claudin18.2 Monoclonal Antibody AB011</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Peldesine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Hydroxyprogesterone Caproate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PRMT5 Inhibitor JNJ-64619178</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Etarotene</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Afimoxifene</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Y 90 Monoclonal Antibody HMFG1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vosilasarm</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-ILDR2 Monoclonal Antibody BAY 1905254</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ITK Inhibitor CPI-818</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-BCMA/CD3 BiTE Antibody REGN5458</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-TIM3 Monoclonal Antibody LY3321367</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Axatilimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CD80-Fc Fusion Protein FPT155</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Thymidylate Synthase Inhibitor DFP-11207</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-DLL3/CD3 BiTE Antibody AMG 757</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">p53 Peptide Vaccine MPS-128</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rilotumumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">APE1/Ref-1 Redox Inhibitor APX3330</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CTLA-4 Monoclonal Antibody AGEN1181</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">IL-12sc, IL-15sushi, IFNa and GM-CSF mRNA-based Immunotherapeutic Agent SAR441000</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cetuximab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nedisertib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Uzansertib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ganoderma lucidum Spores Powder Capsule</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-B7-H4 Monoclonal Antibody FPA150</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">FLT3/KIT Kinase Inhibitor AKN-028</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ruthenium-based Transferrin Targeting Agent NKP-1339</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Multitargeted Tyrosine Kinase Inhibitor JNJ-26483327</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Camidanlumab Tesirine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fenretinide Lipid Matrix</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-EGFR/CD16A Bispecific Antibody AFM24</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Emactuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-hepcidin Monoclonal Antibody LY2787106</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-mesothelin-Pseudomonas Exotoxin 24 Cytolytic Fusion Protein LMB-100</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Buserelin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Hafnium Oxide-containing Nanoparticles NBTXR3</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">B-Raf/VEGFR-2 Inhibitor RAF265</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">FGFR Inhibitor CPL304110</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody 7C11</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-LAG3 Monoclonal Antibody BI 754111</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Interferon Alfa</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Enloplatin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cord Blood Derived CAR T-Cells</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">JAK1 Inhibitor INCB052793</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Orelabrutinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pyrazinamide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sulfatinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Therapeutic Liver Cancer Peptide Vaccine IMA970A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ioflubenzamide I-131</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pan HER/VEGFR2 Receptor Tyrosine Kinase Inhibitor BMS-690514</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">OX40L-expressing Oncolytic Adenovirus DNX-2440</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ponatinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Patidegib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Berberine Chloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Interleukin-6</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lucitanib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Briciclib Sodium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Deslorelin Acetate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Personalized ALL-specific Multi-HLA-binding Peptide Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Geldanamycin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cyclin-dependent Kinase Inhibitor PF-06873600</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Diphencyprone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Orteronel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Docetaxel Formulation CKD-810</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sustained-release Mitomycin C Hydrogel Formulation UGN-102</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ASP4132</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Defactinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BiTE Antibody AMG 910</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">AKT Inhibitor ARQ 092</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Antisense Oligonucleotide QR-313</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">LmddA-LLO-chHER2 Fusion Protein-secreting Live-attenuated Listeria Cancer Vaccine ADXS31-164</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Evofosfamide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Enzastaurin Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Filgotinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BTK inhibitor TG-1701</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Yttrium Y 90 Monoclonal Antibody MN-14</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pertuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Glufosfamide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">c-Met Inhibitor AL2846</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">mRNA-based Personalized Cancer Vaccine NCI-4650</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Protein Arginine Methyltransferase 5 Inhibitor PF-06939999</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Alobresib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-HER2 Antibody Conjugated Natural Killer Cells ACE1702</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Docetaxel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CCR2 Antagonist CCX872-B</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MNK1/2 Inhibitor ETC-1907206</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Liver X Receptor beta Agonist RGX-104</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Istiratumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Leflunomide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Procarbazine Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Adecatumumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">EP4 Antagonist INV-1120</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Carboxyamidotriazole</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-C5aR Monoclonal Antibody IPH5401</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">SHP2 Inhibitor RLY-1971</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Carboxyamidotriazole Orotate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Elacestrant</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">D-methionine Formulation MRX-1024</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD33/CD3 Bispecific Antibody JNJ-67571244</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Enteric-Coated TRPM8 Agonist D-3263 Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ISS 1018 CpG Oligodeoxynucleotide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Imatinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Melanoma Monoclonal Antibody hIgG2A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">STAT3 Inhibitor DSP-0337</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-TIGIT Monoclonal Antibody SGN-TGT</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-HER2 ADC DS-8201a</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mocetinostat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Epirubicin Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Synthetic Glioblastoma Tumor-associated Peptides Vaccine Therapy APVAC1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rosuvastatin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Avapritinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Envafolimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Edatrexate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ALK Inhibitor PLB 1003</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-DLL4/VEGF Bispecific Monoclonal Antibody OMP-305B83</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">NY-ESO-1 Plasmid DNA Cancer Vaccine pPJV7611</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rabusertib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pegylated Recombinant Human Arginase I BCT-100</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Thiodiglycol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Burixafor Hydrobromide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">EGFR/VEGFR/RET Inhibitor HA121-28</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">pan-PIM Kinase Inhibitor AZD1208</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BMI1 Inhibitor PTC596</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MEK/Aurora Kinase Inhibitor BI 847325</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pirotinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Yttrium Y 90-labeled Anti-FZD10 Monoclonal Antibody OTSA101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-TWEAK Monoclonal Antibody RG7212</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cetuximab-IR700 Conjugate RM-1929</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Imatinib Mesylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Carzinophilin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Endothelin Receptor Type A Antagonist YM598</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">LMB-7 Immunotoxin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Thalicarpine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CAIX Inhibitor SLC-0111</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Topotecan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Quisinostat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">GITR Agonist MEDI1873</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fc-engineered Anti-CD40 Agonist Antibody 2141-V11</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dynemicin A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Olinvacimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Anti-CD19 CAR TCR-zeta/4-1BB-transduced T-lymphocytes huCART19</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aldoxorubicin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Polyamine Analog SL11093</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Denibulin Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Abituzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cyclodisone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cedefingol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ALK Inhibitor</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cryptophycin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tandutinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Simmitinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Topoisomerase I Inhibitor Genz-644282</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dulanermin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MMP Inhibitor S-3304</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PAK4 Inhibitor PF-03758309</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-GITR Agonistic Monoclonal Antibody ASP1951</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dezapelisib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Choline Kinase Alpha Inhibitor TCD-717</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pancratistatin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Arsenic Trioxide Capsule Formulation ORH 2014</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-EGFR Monoclonal Antibody RO5083945</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">c-Met Inhibitor MK2461</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-1 Monoclonal Antibody GLS-010</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">KRAS G12C Inhibitor MRTX849</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dendritic Cell Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Linsitinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CAIX Inhibitor DTP348</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">FGFR/CSF-1R Inhibitor 3D185</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">mTOR Kinase Inhibitor CC-223</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pegzilarginase</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lead Pb 212 TCMC-trastuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Axalimogene Filolisbac</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD33/CD3 BiTE Antibody AMG 330</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oncolytic Adenovirus Ad5-DNX-2401</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Smoothened Antagonist LDE225 Topical</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MYC-targeting siRNA DCR-MYC</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">c-Kit Inhibitor PLX9486</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MEK Inhibitor WX-554</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Camrelizumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mofarotene</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Trofosfamide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Muparfostat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Imifoplatin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Spiroplatin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Megestrol Acetate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Qilisheng Immunoregulatory Oral Solution</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ovine Submaxillary Mucin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lestaurtinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MetAP2 Inhibitor SDX-7320</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-FLT3/CD3 BiTE Antibody AMG 427</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lapachone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CDK4/6 Inhibitor FCN-437</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-1/Anti-LAG-3 Bispecific Antibody RO7247669</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Iroplact</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-HER2/Auristatin Payload Antibody-drug Conjugate XMT-1522</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Commensal Bacterial Strain Formulation VE800</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rosmantuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Synthetic Plumbagin PCUR-101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Personalized Neoantigen Peptide Vaccine iNeo-Vac-P01</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tefinostat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD73 Monoclonal Antibody BMS-986179</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Thioinosine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-L1 Monoclonal Antibody CS1001</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Staphylococcal Enterotoxin A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PSMA Monoclonal Antibody MDX1201-A488</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sorghum bicolor Supplement</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">mRNA-derived Lung Cancer Vaccine BI 1361849</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BET Inhibitor BAY1238097</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CT2584 HMS</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Apaziquone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Wnt Signaling Pathway Inhibitor SM08502</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CDK2 Inhibitor PF-07104091</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dendritic Cell-Autologous Lung Tumor Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Trametinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Futuximab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Laniquidar</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-AG7 Antibody Drug Conjugate AbGn-107</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Antibody-drug Conjugate SC-004</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pimurutamab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sotorasib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Adenoviral MUC1 Vaccine ETBX-061</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vinzolidine Sulfate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Suramin Sodium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-1 Monoclonal Antibody MGA012</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Placebo</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">TLR-Directed Cationic Lipid-DNA Complex JVRS-100</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">p300/CBP Bromodomain Inhibitor CCS1477</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MCL-1 Inhibitor ABBV-467</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Serclutamab Talirine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BET Inhibitor BMS-986158</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PSMA/CD3 Bispecific Antibody JNJ-63898081</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-IL-15 Monoclonal Antibody AMG 714</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pacritinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Modified Vaccinia Ankara-5T4 Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Annonaceous Acetogenins</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bi-functional Alkylating Agent VAL-083</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oral Milataxel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aclarubicin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Diaziquone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bromebric Acid</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Necitumumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Estrogens, Conjugated</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Wobe-Mugos E</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Radium Ra 223 Dichloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">DHA-Paclitaxel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sitravatinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Glucocorticoid Receptor Antagonist ORIC-101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vitamin D3 Analogue ILX23-7553</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Uprosertib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bromacrylide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CCR2 Antagonist PF-04136309</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bcl-2 Inhibitor APG 2575</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-ICAM-1 Monoclonal Antibody BI-505</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dexanabinol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Alacizumab Pegol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-c-Met Antibody-drug Conjugate TR1801</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rolinsatamab Talirine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Multi-kinase Inhibitor XL092</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ibritumomab Tiuxetan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Anti-ICAM-1-CAR-CD28-4-1BB-CD3zeta-expressing T-cells AIC100</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pelitinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-Melanin Monoclonal Antibody PTI-6D2</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Estrogen Receptor Agonist GTx-758</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Catumaxomab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Liposomal Rhenium Re 186</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MOF Compound RiMO-301</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Raltitrexed</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ambamustine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pomalidomide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Enobosarm</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-IGF-1R Monoclonal Antibody AVE1642</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Isobrucein B</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Audencel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Allogeneic Anti-CD20 CAR T-cells LUCAR-20S</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">EGFR Inhibitor BIBX 1382</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dovitinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tyrosinase:146-156 Peptide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">STING Agonist MK-1454</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sunitinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lupartumab Amadotin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tiazofurin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Anti-BCMA CAR-transduced T-cells KITE-585</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rilimogene Glafolivec</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tucatinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BMS-188797</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ethaselen</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fluorouracil Implant</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Futuximab/Modotuximab Mixture</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rexinoid NRX 194204</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">2,6-Dimethoxyquinone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Clinical Trial Agent</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HAAH Lambda phage Vaccine SNS-301</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Milatuzumab-Doxorubicin Antibody-Drug Conjugate IMMU-110</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Apitolisib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-FLT3 Monoclonal Antibody 4G8-SDIEM</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Devimistat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ATR Kinase Inhibitor BAY1895344</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Actinomycin F1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PD-L1 Inhibitor INCB086550</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD19 Antibody-T-cell Receptor-expressing T-cells ET019003</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nimodipine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Adenovector-transduced AP1903-inducible MyD88/CD40-expressing Autologous PSMA-specific Prostate Cancer Vaccine BPX-201</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Garlic</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Allogeneic Renal Cell Carcinoma Vaccine MGN1601</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Teroxirone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Etanidazole</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Docetaxel/Ritonavir</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">FLT3 Tyrosine Kinase Inhibitor TTT-3002</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-L1/Anti-4-1BB Bispecific Monoclonal Antibody GEN1046</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant PRAME Protein Plus AS15 Adjuvant GSK2302025A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Polymeric Camptothecin Prodrug XMT-1001</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Diazepinomicin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aurora kinase A/B inhibitor TT-00420</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CXCR4/E-selectin Antagonist GMI-1359</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ssRNA-based Immunomodulator CV8102</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">iNKT Cell Agonist ABX196</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-TRAILR2/CDH17 Tetravalent Bispecific Antibody BI 905711</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oncolytic Adenovirus ORCA-010</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Encapsulated Rapamycin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ERK Inhibitor GDC-0994</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">DAB389 Epidermal Growth Factor</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bleomycin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bisnafide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Activin Type 2B Receptor Fc Fusion Protein STM 434</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CDK9 Inhibitor AZD4573</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Masoprocol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Yttrium-90 Polycarbonate Brachytherapy Plaque</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Foritinib Succinate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">C-myb Antisense Oligonucleotide G4460</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Chloroquinoxaline Sulfonamide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Avitinib Maleate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">FGFR4 Inhibitor ICP-105</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mogamulizumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">DTRMWXHS-12/Everolimus/Pomalidomide Combination Agent DTRM-555</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-B7H3 Antibody-drug Conjugate MGC018</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bleomycin A2</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Anti-CD19 CAR-CD28 T-cells ET019002</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Anti-kappa Light Chain CAR-CD28-expressing T-lymphocytes</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-ETBR/MMAE Antibody-Drug Conjugate DEDN6526A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Valemetostat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ethyleneimine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Apilimod Dimesylate Capsule</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Allogeneic GM-CSF-secreting Tumor Vaccine PANC 10.05 pcDNA-1/GM-Neo</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody HeFi-1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ifosfamide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ilorasertib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">TGF-beta Receptor 1 Inhibitor PF-06952229</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Arfolitixorin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">17beta-Hydroxysteroid Dehydrogenase Type 5 Inhibitor ASP9521</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Carbogen</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Erythrocyte-encapsulated L-asparaginase Suspension</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Telisotuzumab Vedotin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Suramin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Arginase Inhibitor INCB001158</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Superoxide Dismutase Mimetic GC4711</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-LILRB4 Monoclonal Antibody IO-202</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">APC8015F</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cereblon E3 Ubiquitin Ligase Modulating Agent CC-92480</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Z-Endoxifen Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-TROP2 Antibody-drug Conjugate SKB264</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oleclumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Notch Signaling Inhibitor PF-06650808</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Merestinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HPV DNA Plasmids Therapeutic Vaccine VGX-3100</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Donafenib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">G-Quadruplex Stabilizer BMVC</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD123/CD3 BiTE Antibody SAR440234</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lonafarnib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-1/Anti-PD-L1 Bispecific Antibody IBI318</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Penicillamine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tinzaparin Sodium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Multifunctional/Multitargeted Anticancer Agent OMN54</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">WT1/PSMA/hTERT-encoding Plasmid DNA INO-5401</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vitespen</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Polyamine Transport Inhibitor AMXT-1501 Dicaprate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">RAD51 Inhibitor CYT-0851</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Neoantigen-based Renal Cell Carcinoma-Poly-ICLC Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Indoximod</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Motolimod</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">H-ras Antisense Oligodeoxynucleotide ISIS 2503</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bisantrene</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-OX40 Agonist Monoclonal Antibody ABBV-368</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Iodine I 131 Monoclonal Antibody CC49-deltaCH2</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">DI-Leu16-IL2 Immunocytokine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD25-PBD Antibody-drug Conjugate ADCT-301</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Betaglucin Gel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bexarotene</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">XPO1 Inhibitor SL-801</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Interferon Alfa-2a</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">EGFR Inhibitor AZD3759</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody 3622W94</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Selective Estrogen Receptor Modulator CC-8490</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Neoantigen-based Therapeutic Cancer Vaccine GRT-C903</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Amsacrine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mutant p53 Activator COTI-2</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Merbarone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tetradecanoylphorbol Acetate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Deoxycytidine Analogue TAS-109 Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ridaforolimus</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tanomastat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Actinium Ac-225 Anti-PSMA Monoclonal Antibody J591</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Adagloxad Simolenin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">EGb761</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">WT1 Peptide Vaccine OCV-501</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lapatinib Ditosylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HDAC/EGFR/HER2 Inhibitor CUDC-101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Liposomal Bcl-2 Antisense Oligonucleotide  BP1002</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Anti-HLA-A*0201/AFP CAR T-cells ET1402L1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-HER2/PBD-MA Antibody-drug Conjugate DHES0815A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Niclosamide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Allogeneic CRISPR-Cas9 Engineered Anti-CD70 CAR-T Cells CTX130</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Agonistic Anti-OX40 Monoclonal Antibody MEDI6469</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">IDO-1 Inhibitor LY3381916</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">TGFbeta Receptor Ectodomain-IgG Fc Fusion Protein AVID200</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Teglarinad</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">LRP5/6 Antagonist BI 905677</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sorafenib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Doxorubicin-loaded EGFR-targeting Nanocells</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HER2-targeted DARPin MP0274</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Paclitaxel Poliglumex</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Enzastaurin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Bispecific Single-Chain Antibody rM28</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Yttrium Y 90 Glass Microspheres</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HPV E6/E7 DNA Vaccine GX-188E</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cilengitide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Uproleselan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Enclomiphene Citrate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Trifluridine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dexamethasone Sodium Phosphate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nogalamycin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aurora Kinase/VEGFR2 Inhibitor CYC116</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Itacitinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bactobolin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BET Inhibitor FT-1101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Prexasertib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fimepinostat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Glumetinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lucanthone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bcr-Abl Kinase Inhibitor PF-114</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CD47 Antagonist ALX148</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nelarabine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Abexinostat Tosylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Staphylococcal Enterotoxin B</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BET Inhibitor ABBV-744</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">DACH-Platin Micelle NC-4016</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Proapoptotic Sulindac Analog CP-461</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Roneparstat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mivavotinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD70 Antibody-Drug Conjugate MDX-1203</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Degarelix Acetate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-DR5 Agonistic Antibody DS-8273a</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ingenol Mebutate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD33 Monoclonal Antibody BI 836858</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Vesicular Stomatitis Virus-expressing Human Interferon Beta and Sodium-Iodide Symporter</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Beauvericin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Allosteric ErbB Inhibitor BDTX-189</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vofatamab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nintedanib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Neoantigen-based Glioblastoma Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CEBPA-targeting saRNA MTL-CEBPA Liposome</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Anti-CD19 CAR-expressing T-lymphocytes CLIC-1901</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">TLR7 Agonist 852A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Verapamil</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Antibody-drug Conjugate SC-006</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CL 246738</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Xisomab 3G3</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Gentuximab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Broxuridine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HDM2 Inhibitor MK-8242</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Trapoxin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-1/Anti-HER2 Bispecific Antibody IBI315</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PKN3 siRNA Atu027</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">LSD1 Inhibitor CC-90011</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Irinotecan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Deferoxamine Mesylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody D6.12</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PARP 1/2 Inhibitor NOV1401</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Gilteritinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Liposome-encapsulated Daunorubicin-Cytarabine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pirarubicin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ertumaxomab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bovine Cartilage</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">LMP2-specific T Cell Receptor-transduced Autologous T-lymphocytes</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PPAR Alpha Antagonist TPST-1120</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Miltefosine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nanoparticle-encapsulated Doxorubicin Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Doxercalciferol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD38/CD3 Bispecific Monoclonal Antibody GBR 1342</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Immunocytokine NHS-IL12</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Valproic Acid</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Letrozole</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">AXL Receptor Tyrosine Kinase/cMET Inhibitor BPI-9016M</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Olmutinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Retinoic Acid Agent Ro 16-9100</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Polyamine Analogue PG11047</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aminocamptothecin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pegargiminase</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ribociclib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Galunisertib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD3/CD38 Bispecific Monoclonal Antibody AMG 424</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pan-RAF Inhibitor LY3009120</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pemlimogene Merolisbac</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Niraparib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MAGE-10.A2</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">c-Met Inhibitor ABN401</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-AGS-16 Monoclonal Antibody AGS-16M18</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-TIM-3 Monoclonal Antibody BGB-A425</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Demcizumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">KSP Inhibitor SB-743921</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pterostilbene</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Silmitasertib Sodium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Enpromate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous B-cell/Monocyte-presenting HER2/neu Antigen Vaccine BVAC-B</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Porcupine Inhibitor CGX1321</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Grapiprant</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous CD19-targeted CAR T Cells JWCAR029</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Allogeneic GM-CSF-secreting Tumor Vaccine PANC 6.03 pcDNA-1/GM-Neo</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Allogeneic GM-CSF-secreting Lethally Irradiated Prostate Cancer Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Yttrium Y 90 Basiliximab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Irinotecan-Eluting Beads</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Norgestrel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Semuloparin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oral Topotecan Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">STING Agonist IMSA101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">mRNA-Derived Prostate Cancer Vaccine CV9103</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">WT1 Protein-derived Peptide Vaccine DSP-7888</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">SERD D-0502</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Abexinostat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">2-O, 3-O Desulfated Heparin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Telapristone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Robatumumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Doxorubicin-Eluting Beads</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lipid Nanoparticle Encapsulating mRNAs Encoding Human OX40L/IL-23/IL-36gamma mRNA-2752</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">hTERT Multipeptide/Montanide ISA-51 VG/Imiquimod Vaccine GX 301</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Trodusquemine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HPV16 E7-specific HLA-A*02:01-restricted IgG1-Fc Fusion Protein CUE-101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">TLR Agonist BDB001</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MET Tyrosine Kinase Inhibitor SGX523</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PTEF-b/CDK9 Inhibitor BAY1251152</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Poziotinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ribociclib/Letrozole</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rebastinib Tosylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Hydralazine Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Erbulozole</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Henatinib Maleate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tritylcysteine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Falimarev</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cinacalcet Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Doxorubicin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vandetanib-eluting Radiopaque Bead BTG-002814</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lifirafenib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CTLA4 Antibody Fc Fusion Protein KN044</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oregovomab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Polymer-encapsulated Luteolin Nanoparticle</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Xeloda</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PD-L1/PD-L2/VISTA Antagonist CA-170</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-c-fms Monoclonal Antibody AMG 820</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Thioureidobutyronitrile</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cabazitaxel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CSF1R Monoclonal Antibody SNDX-6352</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ozarelix</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Benzoylphenylurea</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-EGFR/PBD Antibody-drug Conjugate ABBV-321</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD3/CD20 Bispecific Antibody GEN3013</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-1/TIM-3 Bispecific Antibody RO7121661</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Misonidazole</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oncolytic Newcastle Disease Virus Strain PV701</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-GCC Antibody-Drug Conjugate TAK-164</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD19 Monoclonal Antibody XmAb5574</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Synthetic Long HPV16 E6/E7 Peptides Vaccine ISA101b</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Intermediate-affinity Interleukin-2 Receptor Agonist ALKS 4230</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Exisulind</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bleomycin B2</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-HER2 Antibody-drug Conjugate BAT8001</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Glaucarubolone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CYP11A1 Inhibitor ODM-209</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Edelfosine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cinobufagin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Topical Potassium Dobesilate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PIM Kinase Inhibitor LGH447</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody CEP-37250/KHK2804</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Axl/Mer Inhibitor INCB081776</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing T-cells C-CAR088</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lutetium Lu 177 Satoreotide Tetraxetan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Bispecific BCMA/CD19-targeted CAR-T Cells GC012F</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bispecific Antibody GS-1423</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Edodekin alfa</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lung-targeted Immunomodulator QBKPN</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-EphA2 Monoclonal Antibody-MMAF Immunoconjugate MEDI-547</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Tumor Infiltrating Lymphocytes LN-145</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Flumatinib Mesylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Triapine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody 1F5</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Adenosine A2B Receptor Antagonist PBF-1129</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vadimezan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lutetium Lu 177 Monoclonal Antibody CC49</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Androgen Receptor Degrader CC-94676</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Razoxane</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">North American Ginseng Extract AFX-2</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD123 x Anti-CD3 Bispecific Antibody XmAb1404</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fenretinide Phospholipid Suspension ST-001</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pixantrone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aurora Kinase Inhibitor TTP607</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Hypericin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-AXL/PBD Antibody-drug Conjugate ADCT-601</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Adenovirus Serotype 26-expressing HPV18 Vaccine JNJ-63682931</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Essiac</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD40/Anti-4-1BB Bispecific Agonist Monoclonal Antibody GEN1042</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mycophenolic Acid</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pyruvate Kinase M2 Isoform Activator TP-1454</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Acivicin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lutetium Lu-177 PSMA-R2</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Adenovirus-mediated Human Interleukin-12 INXN-2001 Plus Activator Ligand INXN-1001</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bcr-Abl Kinase Inhibitor K0706</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Chk1 Inhibitor GDC-0425</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vorsetzumab Mafodotin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant KSA Glycoprotein CO17-1A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-HER2 Bispecific Antibody-drug Conjugate ZW49</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Estramustine Phosphate Sodium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Menogaril</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Amolimogene Bepiplasmid</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Utomilumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Yttrium Y 90 Anti-CD45 Monoclonal Antibody BC8</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Floxuridine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Dendritic Cell Vaccine ACT2001</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lenalidomide Analog KPG-121</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Therapeutic Hydrocortisone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">TLR9 Agonist AST-008</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Liposomal Vinorelbine Tartrate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Magrolimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mitomycin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Clonal Neoantigen T Cells ATL001</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">JAK1 Inhibitor AZD4205</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rociletinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bimiralisib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ALK Inhibitor ASP3026</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Allogeneic Anti-CD19 CAR T-cells ALLO-501A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">pan-PI3K Inhibitor CLR457</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tamibarotene</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nimustine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bruceanol G</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Trientine Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Etoposide Phosphate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aviscumine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mechlorethamine Hydrochloride Gel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Interleukin-13</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pazopanib Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Giredestrant</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cidan Herbal Capsule</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Zinc Finger Nuclease ZFN-603</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Zanidatamab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bushen Culuan Decoction</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pimitespib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">7-Hydroxystaurosporine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">P-TEFb Inhibitor BAY1143572</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cemadotin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Progestational IUD</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sofituzumab Vedotin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Plevitrexed</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ceritinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Human Apolipoprotein(a) Kringle V MG1102</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ Central Memory T-lymphocytes JCAR014</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Antineoplaston A10</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-A5B1 Integrin Monoclonal Antibody PF-04605412</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">TORC1/2 Kinase Inhibitor DS-3078a</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Liposomal c-raf Antisense Oligonucleotide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HIF-1alpha Inhibitor PX-478</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Docetaxel-loaded Nanopharmaceutical CRLX301</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Refametinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Kanitinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Siremadlin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MAGE-A4-specific TCR Gene-transduced Autologous T Lymphocytes TBI-1201</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Interferon Gamma-1b</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tyrosine Kinase Inhibitor TL-895</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Gefitinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-TIGIT Monoclonal Antibody COM902</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Navicixizumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-EGFR/c-Met Bispecific Antibody EMB-01</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Padoporfin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Serine/Threonine Kinase Inhibitor XL418</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Akt Inhibitor SR13668</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Miptenalimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BCG Tokyo-172 Strain Solution</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">c-Met Inhibitor HS-10241</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ladiratuzumab Vedotin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Brivanib Alaninate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">EGFR Mutant-specific Inhibitor ZN-e4</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MVX-1-loaded Macrocapsule/autologous Tumor Cell Vaccine MVX-ONCO-1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">2-Hydroxyoleic Acid</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Inactivated Oncolytic Virus Particle GEN0101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous TCR-engineered T-cells IMA202</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Alanosine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Polyandrol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sapanisertib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Thorium Th 227 Anti-HER2 Monoclonal Antibody BAY2701439</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vatalanib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BRD4 Inhibitor PLX2853</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-GITR Agonistic Monoclonal Antibody INCAGN01876</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">RORgamma Agonist LYC-55716</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-B7-H3/DXd Antibody-drug Conjugate DS-7300a</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody AK002</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Iodine I 131 Monoclonal Antibody muJ591</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Human Combinatorial Antibody Library-based Monoclonal Antibody VAY736</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CXCR4 Antagonist USL311</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Opioid Growth Factor</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PI3K-delta Inhibitor AMG 319</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PAK4/NAMPT Inhibitor KPT-9274</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">FLT3 Inhibitor SKI-G-801</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-LAG-3/PD-L1 Bispecific Antibody FS118</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-nf-P2X7 Antibody Ointment BIL-010t</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">E2F1 Pathway Activator ARQ 171</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Inosine Monophosphate Dehydrogenase Inhibitor AVN944</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Elliptinium Acetate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Multi-lineage Potential Cells</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Motesanib Diphosphate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cintredekin Besudotox</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tecogalan Sodium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sevacizumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD70 Monoclonal Antibody MDX-1411</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Trimetrexate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-MUC1 Monoclonal Antibody BTH1704</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bizalimogene Ralaplasmid</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">RET Mutation/Fusion Inhibitor BLU-667</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dabrafenib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-ANG2 Monoclonal Antibody MEDI-3617</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mevociclib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody 14G2A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Metamelfalan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Melphalan Flufenamide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Piperazinedione</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Antineoplastic Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CXC Chemokine Receptor 2 Antagonist AZD5069</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tris-acryl Gelatin Microspheres</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">EGFR/HER2 Inhibitor AV-412</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Becatecarin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Marimastat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Microbiome-derived Peptide Vaccine EO2401</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-AGS-8 Monoclonal Antibody AGS-8M4</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Resveratrol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Carfilzomib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Immunomodulatory Agent CC-11006</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">FLT3/KIT/CSF1R Inhibitor NMS-03592088</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rilimogene Galvacirepvec</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Plinabulin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Metarrestin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD47/CD19 Bispecific Monoclonal Antibody TG-1801</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Human TRAIL-Trimer Fusion Protein SCB-313</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ranolazine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Calcium Saccharate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CTLA-4/Anti-PD-1 Monoclonal Antibody Combination BCD-217</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">SHP2 Inhibitor JAB-3068</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">THL-P</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rogaratinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PBN Derivative OKN-007</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Multi-kinase Inhibitor TPX-0022</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Gamma-delta Tocotrienol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Valspodar</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">2'-F-ara-deoxyuridine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pamiparib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bazlitoran</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vandortuzumab Vedotin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Allodepleted T Cell Immunotherapeutic ATIR101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tegafur-gimeracil-oteracil Potassium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-1 Monoclonal Antibody 609A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Goserelin Acetate Extended-release Microspheres LY01005</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">IDO1/TDO2 Inhibitor M4112</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CTLA-4 Monoclonal Antibody ADU-1604</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">FASN Inhibitor TVB-2640</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Urokinase-Derived Peptide A6</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Amrubicin Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Opaganib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fumagillin-Derived Polymer Conjugate XMT-1107</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">2-Deoxy-D-glucose</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Humanized Anti-HER-2 Bispecific Monoclonal Antibody MBS301</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Simurosertib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-GITR Monoclonal Antibody MK-4166</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pixantrone Dimaleate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ERK 1/2 Inhibitor ASTX029</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">pan-HER Kinase Inhibitor AC480</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">AR Antagonist BMS-641988</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">EP2/EP4 Antagonist TPST-1495</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Inositol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Neoantigen-based Therapeutic Cancer Vaccine GRT-R904</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Archexin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD26 Monoclonal Antibody YS110</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-IL-13 Humanized Monoclonal Antibody TNX-650</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-TIGIT Monoclonal Antibody BGB-A1217</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ocaratuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Shu Yu Wan Formula</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Hematoporphyrin Derivative</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Strontium Chloride Sr-89</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fluorodopan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cannabidiol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ublituximab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ras Peptide VAL</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CBP/beta-catenin Modulator E7386</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">12-Allyldeoxoartemisinin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-1 Monoclonal Antibody AMG 404</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PSMA/CD28 Bispecific Antibody REGN5678</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Angiopoietin-2-specific Fusion Protein PF-04856884</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD3/Anti-GUCY2C Bispecific Antibody PF-07062119</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Triazinate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-DKK1 Monoclonal Antibody BHQ880</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Seliciclib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PI3K-delta Inhibitor INCB050465</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Piritrexim</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Brostacillin Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Trametinib Dimethyl Sulfoxide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Immunotherapy Regimen MKC-1106-MT</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Anti-CD19/CD22 CAR T-cells AUTO3</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fimaporfin A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ambazone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Saccharomyces Cerevisia-CEA(610D)-Expressing Vaccine GI-6207</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Parvovirus H-1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Procarbazine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vinflunine Ditartrate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oral Docetaxel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">IRAK4 Inhibitor CA-4948</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ifetroban</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD166 Probody-drug Conjugate CX-2009</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oncolytic Virus ASP9801</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cantuzumab Ravtansine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">siRNA-transfected Peripheral Blood Mononuclear Cells APN401</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Retrovector Encoding Mutant Anti-Cyclin G1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cytidine Analog RX-3117</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD20 Monoclonal Antibody PRO131921</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">LMB-9 Immunotoxin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Carzelesin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CTLA-4 Monoclonal Antibody MK-1308</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pumitepa</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Paclitaxel Vitamin E-Based Emulsion</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lenzilumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Amsilarotene</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Encorafenib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD137 Agonistic Monoclonal Antibody ADG106</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Talmapimod</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Indomethacin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody 11D10 Anti-Idiotype Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MCL-1 inhibitor AMG 397</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Carboquone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Allogeneic Anti-BCMA/CS1 Bispecific CAR-T Cells</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody IMMU-14</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Namirotene</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Artemether Sublingual Spray</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MAGE-A3 Peptide Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Baltaleucel-T</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ripertamab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Carboplatin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Selective Estrogen Receptor Degrader AZD9833</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Opucolimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mitomycin A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">IL-2/9/15 Gamma Chain Receptor Inhibitor BNZ-1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vistusertib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Integrin Receptor Antagonist GLPG0187</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ponatinib Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Chaparrinone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mivobulin Isethionate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Anti-CD19CAR-HER2t/CD22CAR-EGFRt-expressing T-cells</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">R-(-)-Gossypol Acetic Acid</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Apoptosis Inducer GCS-100</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PI3K-beta Inhibitor SAR260301</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Glioma Lysate Vaccine GBM6-AD</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Modified Vitamin D Binding Protein Macrophage Activator EF-022</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Hydrocortisone Sodium Succinate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-TIM-3 Monoclonal Antibody Sym023</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">iNOS Dimerization Inhibitor ASP9853</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Adenoviral Cancer Vaccine PF-06936308</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Antibody-drug Conjugate ABBV-155</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Brostallicin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aerosolized Aldesleukin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Brivudine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Staurosporine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-TIM-3 Monoclonal Antibody TSR-022</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CK1alpha/CDK7/CDK9 Inhibitor BTX-A51</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Abiraterone Acetate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-ENPP3/MMAF Antibody-Drug Conjugate AGS-16M8F</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">G Protein-coupled Estrogen Receptor Agonist LNS8801</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Androgen Receptor Antagonist BAY 1161116</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Octreotide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pegylated Recombinant Interleukin-2 THOR-707</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Linoleyl Carbonate-Paclitaxel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tocladesine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Astuprotimut-R</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ceralasertib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pyridyl Cyanoguanidine CHS 828</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CTLA-4 Monoclonal Antibody ADG116</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PIM Kinase Inhibitor TP-3654</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lipid Nanoparticle Encapsulated OX40L mRNA-2416</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Asciminib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CXCR2 Antagonist QBM076</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">pDNA-encoding Emm55 Autologous Cancer Cell Vaccine IFx-Hu2.0</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Galectin-1 Inhibitor OTX008</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Androgen Receptor Antisense Oligonucleotide AZD5312</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Arnebia Indigo Jade Pearl Topical Cream</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Guanabenz Acetate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD33/CD3 BiTE Antibody AMG 673</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-TGF-beta RII Monoclonal Antibody IMC-TR1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">9H-Purine-6Thio-98D</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Retinyl Acetate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Regorafenib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Human Papillomavirus Nonavalent Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Glucarpidase</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Galectin Inhibitor GR-MD-02</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Troxacitabine Nucleotide Prodrug MIV-818</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tretinoin Liposome</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">mRNA-derived KRAS-targeted Vaccine V941</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">KSP Inhibitor AZD4877</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">EGFR/EGFRvIII Inhibitor WSD0922-FU</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Immune Checkpoint Inhibitor ASP8374</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">SMAC Mimetic BI 891065</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Exicorilant</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Prexigebersen</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CTGF Monoclonal Antibody FG-3019</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Talotrexin Ammonium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sodium Metaarsenite</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Itacitinib Adipate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pegylated Liposomal Doxorubicin Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oral Microencapsulated Diindolylmethane</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Eltanexor</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">FGFR Inhibitor ASP5878</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rezivertinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Azapicyl</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Synchrovax SEM Plasmid DNA Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lifileucel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Racemetyrosine/Methoxsalen/Phenytoin/Sirolimus SM-88</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Alvocidib Prodrug TP-1287</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">IDO1 Inhibitor PF-06840003</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sapacitabine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD20/CD3 Monoclonal Antibody XmAb13676</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Methazolamide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Buparlisib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ixabepilone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Crenolanib Besylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Src Kinase Inhibitor KX2-391 Ointment</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Poliglusam</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MDM2 Antagonist RO5045337</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Gonadotropin-releasing Hormone Analog</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lisocabtagene Maraleucel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CDK4/6 Inhibitor BPI-16350</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Peplomycin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Multi-neo-epitope Vaccine OSE 2101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Inulin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-HER2/Anti-CD3 Bispecific Monoclonal Antibody GBR 1302</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cenersen</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Bi-epitope BCMA-targeted CAR T-cells JNJ-68284528</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">STING Agonist GSK3745417</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-LAMP1 Antibody-drug Conjugate SAR428926</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody F19</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Carboxyphenyl Retinamide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD117 Monoclonal Antibody JSP191</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">LOXL2 Inhibitor PAT-1251</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bosutinib Monohydrate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tanespimycin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Olivomycin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Personalized Peptide Cancer Vaccine NEO-PV-01</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody 3F8</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD352 Antibody-drug Conjugate SGN-CD352A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Naxitamab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody E2.3</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nanoparticle Albumin-bound Thiocolchicine Dimer nab-5404</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aranose</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CSF1R Inhibitor PLX73086</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pyrazoloacridine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">GI-4000 Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD19/CD3 Tetravalent Antibody AFM11</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tozasertib Lactate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Codrituzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">STING Agonist TAK-676</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Labetuzumab Govitecan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Caracemide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mitobronitol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Synthetic Glioblastoma Mutated Tumor-specific Peptides Vaccine Therapy APVAC2</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody 11D10</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tosedostat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Allogeneic Third-party Suicide Gene-transduced Anti-HLA-DPB1*0401 CD4+ T-cells CTL 19</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Flotetuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BMS-275183</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mosunetuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PD-L1 Inhibitor GS-4224</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">VEGF/HGF-targeting DARPin MP0250</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HIF-2alpha Inhibitor PT2385</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mitolactol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aerosolized Liposomal Rubitecan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Transforming Growth Factor-Beta-2</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Folic Acid</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sonolisib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rivoceranib Mesylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Arugula Seed Powder</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Interferon Alfa-N1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oral Fludarabine Phosphate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-EGP-2 Immunotoxin MOC31-PE</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oncolytic HSV-1 NV1020</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Herbimycin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ER alpha Proteolysis-targeting Chimera Protein Degrader ARV-471</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Inebilizumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dexamethasone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cytarabine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fluvastatin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pan-FGFR Inhibitor LY2874455</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Brontictuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ALK/c-Met Inhibitor  TQ-B3139</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Alpha-Gal AGI-134</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Trastuzumab Conjugate BI-CON-02</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PI3K/mTORC1/mTORC2 Inhibitor DCBCI0901</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Akt Inhibitor MK2206</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Selpercatinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pegylated Liposomal Belotecan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Capmatinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody muJ591</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Theramide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">S-equol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Duborimycin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pioglitazone Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">IGF-1R Inhibitor PL225B</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PI3K p110beta/delta Inhibitor KA2237</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Paclitaxel Ceribate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tolnidamine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rogletimide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Algenpantucel-L</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Idronoxil</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cyclosporine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ALK-FAK Inhibitor CEP-37440</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vintafolide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-EGFR Monoclonal Antibody GT-MAB 5.2-GEX</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dendritic Cell-targeting Lentiviral Vector ID-LV305</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">RFT5-dgA Immunotoxin IMTOX25</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tretinoin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Gandotinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mitotenamine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Brivudine Phosphoramidate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Carlumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-BCMA Antibody-drug Conjugate CC-99712</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cibisatamab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Allogeneic Natural Killer Cell Line NK-92</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Adenosine A2A Receptor Antagonist/Phosphodiesterase 10A PBF-999</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Daunorubicin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PARP/Tankyrase Inhibitor 2X-121</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Capecitabine Rapidly Disintegrating Tablet</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Combretastatin A-1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Receptor Tyrosine Kinase Inhibitor R1530</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nimotuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Deslorelin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Anti-BCMA-CAR-expressing CD4+/CD8+ T-lymphocytes FCARH143</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Amblyomin-X</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Trastuzumab Emtansine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Guselkumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Copanlisib Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anthrapyrazole</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lenvatinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Interleukin-18</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ALK Inhibitor TAE684</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ilixadencel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PARP Inhibitor AZD2461</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Adenoviral PSA Vaccine ETBX-071</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">3'-C-ethynylcytidine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Daporinad</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Parsaclisib Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ruxolitinib Phosphate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CDK Inhibitor AT7519</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-EGFR Monoclonal Antibody HLX-07</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Elliptinium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">DNMT1 Mixed-Backbone Antisense Oligonucleotide MG 98</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ruthenium-based Small Molecule Therapeutic BOLD-100</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mibefradil Dihydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">USP14/UCHL5 Inhibitor VLX1570</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Landogrozumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Talactoferrin Alfa</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dynemicin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pelitrexol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-gpA33/CD3 Monoclonal Antibody MGD007</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Porcupine Inhibitor RXC004</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">c-Met Inhibitor AMG 208</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Plicamycin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BCMA x CD3 T-cell Engaging Antibody CC-93269</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MEK Inhibitor HL-085</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rhenium Re-188 Ethiodized Oil</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ofatumumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Trastuzumab Deruxtecan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Eftozanermin Alfa</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Crolibulin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Indusatumab Vedotin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CDC7 Inhibitor TAK-931</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Laetrile</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ropidoxuridine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Liposome-encapsulated RB94 Plasmid DNA Gene Therapy Agent SGT-94</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mitozolomide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous CRISPR-edited Anti-CD19 CAR T Cells XYF19</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Balstilimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Siplizumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Retaspimycin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Spanlecortemlocel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Uncaria tomentosa Extract</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous MCPyV-specific HLA-A02-restricted TCR-transduced CD4+ and CD8+ T-cells FH-MCVA2TCR</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CDK2/4/6/FLT3 Inhibitor FN-1501</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Foslinanib Disodium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MDM2 Antagonist ASTX295</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-alpha BCMA/Anti-alpha CD3 T-cell Engaging Bispecific Antibody TNB-383B</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">EZH2 inhibitor CPI-0209</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Liposomal Eribulin Mesylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dactolisib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-1 Monoclonal Antibody SCT-I10A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Copper Gluconate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Golotimod</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ncmtRNA Oligonucleotide Andes-1537</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">SIRPa-4-1BBL Fusion Protein DSP107</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fosquidone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dienogest</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HPV16 L2/E6/E7 Fusion Protein Vaccine TA-CIN</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Therapeutic Cancer Vaccine ATP128</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Etoprine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Azotomycin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lexatumumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aminocamptothecin Colloidal Dispersion</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">FGFR4 Inhibitor FGF401</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Parsatuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ALK-2 Inhibitor TP-0184</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Molibresib Besylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Liposomal SN-38</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nedaplatin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Atiprimod Dimaleate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Iodine I 131 Omburtamab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Src Kinase Inhibitor KX2-391</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Alkotinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lutetium Lu-177 Rituximab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-TIGIT Monoclonal Antibody OMP-313M32</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Prednisone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aurora Kinase Inhibitor AMG 900</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Liposomal Daunorubicin Citrate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pamrevlumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Tumor Necrosis Factor-Alpha</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Transferrin Receptor-Targeted Liposomal p53 cDNA</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Glembatumumab Vedotin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CD73 Inhibitor LY3475070</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Plozalizumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oncolytic HSV-1 C134</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">WT1 Peptide Vaccine WT2725</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Solitomab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nagrestipen</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Zelavespib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Thymopentin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Doxorubicin-Magnetic Targeted Carrier Complex</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Deep IL-15 Primed T-cells TRQ15-01</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lisavanbulin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CDK/JAK2/FLT3 Inhibitor TG02 Citrate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Engineered Toxin Body Targeting HER2 MT-5111</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Marcellomycin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">TLC ELL-12</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nanoparticle Albumin-Bound Rapamycin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Etidronate-Cytarabine Conjugate MBC-11</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CD28/ICOS Antagonist ALPN-101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Isatuximab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Micro Needle Array-Doxorubicin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Testosterone Enanthate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Abiraterone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">DM4-Conjugated Anti-Cripto Monoclonal Antibody BIIB015</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Broccoli Sprout/Broccoli Seed Extract Supplement</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HPPH</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tigatuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sotrastaurin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cisplatin/Vinblastine/Cell Penetration Enhancer Formulation INT230-6</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bendamustine Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MVA-FCU1 TG4023</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cetuximab Sarotalocan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-EGFR Monoclonal Antibody GC1118</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Methoxsalen</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Interferon-gamma-expressing Adenovirus Vaccine ASN-002</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-Ep-CAM Monoclonal Antibody ING-1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Gamma-Secretase Inhibitor RO4929097</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Platinum Compound</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pexastimogene Devacirepvec</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">mTORC1/mTORC2/DHFR Inhibitor ABTL0812</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cantrixil</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aurora B Serine/Threonine Kinase Inhibitor TAK-901</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Plk1 Inhibitor BI 2536</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Protease-activated Anti-PD-L1 Antibody Prodrug CX-072</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Enzalutamide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Canertinib Dihydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal T-cell Receptor Anti-CD3 scFv Fusion Protein IMCgp100</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Chromomycin A3</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mycobacterium w</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-Myeloma Monoclonal Antibody-DM4 Immunoconjugate BT-062</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Transdermal 17beta-Estradiol Gel BHR-200</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BET Inhibitor RO6870810</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Reparixin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Class 1/4 Histone Deacetylase Inhibitor OKI-179</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BRAF(V600E) Kinase Inhibitor RO5212054</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lyophilized Black Raspberry Saliva Substitute</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MEK 1/2 Inhibitor FCN-159</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PGLA/PEG Copolymer-Based Paclitaxel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sepantronium Bromide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD205 Antibody-drug Conjugate OBT076</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cabozantinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-HER3 Monoclonal Antibody GSK2849330</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dexrazoxane Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Interferon Alpha 2b-like Protein</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dual Variable Domain Immunoglobulin ABT-165</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-L1/IL-15 Fusion Protein KD033</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">FAP/4-1BB-targeting DARPin MP0310</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dalotuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Flt3 Ligand/Anti-CTLA-4 Antibody/IL-12 Engineered Oncolytic Vaccinia Virus RIVAL-01</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD19/CD22 CAR NK Cells</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">mRNA-derived Prostate Cancer Vaccine CV9104</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pazopanib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Apoptosis Inducer MPC-2130</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-SLITRK6 Monoclonal Antibody-MMAE Conjugate AGS15E</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anakinra</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Octreotide Pamoate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-human GITR Monoclonal Antibody TRX518</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">DNA-PK/TOR Kinase Inhibitor CC-115</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-1/VEGF Bispecific Antibody AK112</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vinorelbine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Histrelin Acetate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">IGF-1R/IR Inhibitor KW-2450</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Double-armed TMZ-CD40L/4-1BBL Oncolytic Ad5/35 Adenovirus LOAd703</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">AEE788</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Naquotinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ketotrexate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nelipepimut-S Plus GM-CSF Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CDK7 Inhibitor SY-1365</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">FMS Inhibitor JNJ-40346527</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Almurtide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Brivanib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-RANKL Monoclonal Antibody JMT103</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CDK1 Inhibitor BEY1107</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Binetrakin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Gatipotuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD30/DM1 Antibody-drug Conjugate F0002</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">4-Nitroestrone 3-Methyl Ether</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Medorubicin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">LMB-1 Immunotoxin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Samrotamab Vedotin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Topotecan Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">2-Ethylhydrazide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Azurin:50-77 Cell Penetrating Peptide p28</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD122 Humanized Monoclonal Antibody Mik-Beta-1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ciforadenant</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">NA17-A Antigen</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Phenesterin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Empesertib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Azacitidine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Eicosapentaenoic Acid</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Imiquimod</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Linifanib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tergenpumatucel-L</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tremelimumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Wee1 Inhibitor ZN-c3</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PIM/FLT3 Kinase Inhibitor SEL24</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Allogeneic IL13-Zetakine/HyTK-Expressing-Glucocorticoid Resistant Cytotoxic T Lymphocytes GRm13Z40-2</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">FLT3/CDK4/6 Inhibitor FLX925</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-HER2 Antibody-drug Conjugate RC48</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Anti-CD19 CAR-4-1BB-CD3zeta-expressing T-cells CNCT19</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Taltobulin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Felzartamab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Triazene Derivative TriN2755</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Glutaminase Inhibitor CB-839</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lorukafusp alfa</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-HER2 Monoclonal Antibody HLX22</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dicycloplatin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Gimeracil</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ovapuldencel-T</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CYP17 Inhibitor CFG920</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Idarubicin Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Glyco-engineered Anti-CD20 Monoclonal Antibody CHO H01</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Alestramustine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lazertinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Wee1 Kinase Inhibitor Debio 0123</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CEACAM6 AFAIKL2 Antibody Fragment/Jack Bean Urease Immunoconjugate L-DOS47</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Prostaglandin E2 EP4 Receptor Inhibitor E7046</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-myostatin Monoclonal Antibody LY2495655</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">4-Thio-2-deoxycytidine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oligo-fucoidan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dolastatin 15</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tisagenlecleucel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Liothyronine I-131</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Noscapine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD20/Anti-CD3 Bispecific IgM Antibody IGM2323</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tertomotide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Alpha V Beta 8 Antagonist PF-06940434</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ricolinostat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD137 Agonistic Monoclonal Antibody AGEN2373</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Zanubrutinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Topsalysin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">STAT Inhibitor OPB-111077</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Interleukin-12-Fc Fusion Protein DF6002</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">S-Adenosylmethionine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Yttrium Y 90 Monoclonal Antibody BrE-3</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Esorubicin Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nadofaragene Firadenovec</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fosaprepitant</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-ErbB3 Monoclonal Antibody AV-203</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Interleukin-15/Interleukin-15 Receptor Alpha Sushi+ Domain Fusion Protein SO-C101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">FGFR Inhibitor AZD4547</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Transferrin-CRM107</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Midostaurin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dacomitinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PRAME-targeting T-cell Receptor/Inducible Caspase 9 BPX-701</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Doxorubicin Prodrug L-377,202</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Manelimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Live-Attenuated Listeria Encoding Human Mesothelin Vaccine CRS-207</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Interleukin-2</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Multi-epitope HER2 Peptide Vaccine TPIV100</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Boronophenylalanine-Fructose Complex</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sugemalimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Seocalcitol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Synthetic Long E6 Peptide-Toll-like Receptor Ligand Conjugate Vaccine ISA201</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Goserelin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">IGF-1R Inhibitor</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Depatuxizumab Mafodotin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tebentafusp</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Tetravalent Dendritic Cell Vaccine MIDRIX4-LUNG</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sotigalimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PKA Regulatory Subunit RIalpha Mixed-Backbone Antisense Oligonucleotide GEM 231</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Birinapant</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">pan FGFR Inhibitor PRN1371</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous TAAs-loaded Autologous Dendritic Cells AV-GBM-1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HER2 Tri-specific Natural Killer Cell Engager DF1001</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tiomolibdate Choline</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nucleolin Antagonist IPP-204106N</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vindesine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ras Inhibitor</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Motexafin Gadolinium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nab-paclitaxel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Trastuzumab Duocarmazine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fotemustine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD39 Monoclonal Antibody TTX-030</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Paclitaxel-Loaded Polymeric Micelle</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-sCLU Monoclonal Antibody AB-16B5</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ALK/ROS1/Met Inhibitor TQ-B3101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Picoplatin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">EGFR/HER1/HER2 Inhibitor PKI166</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CDK4/6 Inhibitor HS-10342</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BMS-214662</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Yttrium Y 90-DOTA-di-HSG Peptide IMP-288</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">V930 Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ad-RTS-hIL-12</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous AXL-targeted CAR T-cells CCT301-38</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mitosis Inhibitor T 1101 Tosylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anaxirone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Carubicin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-ICOS Agonist Monoclonal Antibody BMS-986226</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HPV-16 E6 Peptides Vaccine/Candida albicans Extract</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Eg5 Kinesin-Related Motor Protein Inhibitor ARQ 621</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Glecaprevir/Pibrentasvir</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Extended-release Onapristone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PEOX-based Polymer Encapsulated Paclitaxel FID-007</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PI3Kalpha Inhibitor AZD8835</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tipiracil Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rosiglitazone Maleate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Osimertinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">EZH2 Inhibitor CPI-1205</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">GS/pan-Notch Inhibitor BMS-986115</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tyrosine Kinase Inhibitor OSI-930</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD38 Monoclonal Antibody MOR03087</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HDAC Inhibitor CKD-581</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PI3K Inhibitor GDC-0084</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Otlertuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PI3Kbeta Inhibitor AZD8186</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">C-VISA BikDD:Liposome</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Adenovirus-p53 SCH-58500</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Clodronate Disodium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mitindomide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Isocoumarin NM-3</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">EGFR/HER2 Kinase Inhibitor TAK-285</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sulindac</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Balixafortide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Apoptosis Inducer BZL101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ibrutinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">IAP Inhibitor APG-1387</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pegfilgrastim</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Foretinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Prostate Health Cocktail Dietary Supplement</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PEP-3-KLH Conjugate Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">NAMPT Inhibitor OT-82</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Viagenpumatucel-L</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BRD4 Inhibitor PLX51107</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Yttrium Y 90 Monoclonal Antibody Hu3S193</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Multikinase Inhibitor AEE788</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Risperidone Formulation in Rumenic Acid</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Topixantrone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nanafrocin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Volociximab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">LRP5 Antagonist BI 905681</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">LSD1 Inhibitor IMG-7289</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Antibody-drug Conjugate PF-06664178</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Allogeneic Irradiated Melanoma Cell Vaccine CSF470</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cusatuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Palbociclib Isethionate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Endothelin B Receptor Blocker ENB 003</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aerosol Gemcitabine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Prednimustine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Trastuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Live-attenuated Double-deleted Listeria monocytogenes Bacteria JNJ-64041809</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Corticorelin Acetate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ex Vivo-expanded Autologous T Cells IMA101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Protein Arginine Methyltransferase 5 Inhibitor PRT543</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tazemetostat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ketoconazole</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Inosine 5'-monophosphate Dehydrogenase Inhibitor FF-10501-01</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tovetumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Xentuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oncolytic Newcastle Disease Virus MEDI5395</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Maekmoondong-tang</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CA6-DM4 Immunoconjugate SAR566658</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Phaleria macrocarpa Extract DLBS-1425</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Miransertib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Redaporfin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">EGFR Inhibitor PD-168393</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nanoparticle Paclitaxel Ointment SOR007</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD38/CD28xCD3 Tri-specific Monoclonal Antibody SAR442257</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vactosertib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-5T4 Antibody-drug Conjugate ASN004</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Not Reported</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-Nucleolin Aptamer AS1411</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Polymer-conjugated IL-15 Receptor Agonist NKTR-255</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ERK1/2 Inhibitor KO-947</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nurulimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Temarotene</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Eribulin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-1 Monoclonal Antibody F520</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-L1 Monoclonal Antibody BCD-135</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD123 ADC IMGN632</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aurora A Kinase Inhibitor MK5108</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PGF Monoclonal Antibody RO5323441</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Alflutinib Mesylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Temozolomide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Azaribine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Motixafortide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CDK4/6 Inhibitor</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vecabrutinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tivozanib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Daunorubicin Citrate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dihydroorotate Dehydrogenase Inhibitor AG-636</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mitoguazone Dihydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nucleoside Analog DFP-10917</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">EGFR Mutant-specific Inhibitor BPI-7711</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ALK Inhibitor WX-0593</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pentamustine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Iloprost</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-GCC Antibody-Drug Conjugate MLN0264</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tubulin Polymerization Inhibitor VERU-111</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-VEGF/TGF-beta 1 Fusion Protein HB-002T</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Iodine I 131 Anti-Fibronectin Antibody Fragment L19-SIP</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ATM Kinase Inhibitor AZD1390</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rosabulin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Carbendazim</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Elisidepsin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lefitolimod</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-HER2 Antibody-drug Conjugate DP303c</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Daunorubicin Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CTLA4 Monoclonal Antibody BMS-986218</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Onatasertib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD37 MMAE Antibody-drug Conjugate AGS67E</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dihydrolenperone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sardomozide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dacetuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CD40 Agonistic Monoclonal Antibody APX005M</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Human MOAB LICO 28a32</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-Integrin Monoclonal Antibody-DM4 Immunoconjugate IMGN388</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bruceanol B</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Factor VII-targeting Immunoconjugate Protein ICON-1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Zolbetuximab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">JAK Inhibitor</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vinorelbine Tartrate Emulsion</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Seclidemstat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD19 Monoclonal Antibody DI-B4</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Letetresgene Autoleucel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Leuprolide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">SERD GDC-9545</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Octreotide Acetate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Yttrium Y-90 Epratuzumab Tetraxetan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dichloroallyl Lawsone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Triamcinolone Acetonide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Radiolabeled CC49</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Calcitriol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Exemestane</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PI3K/mTOR Kinase Inhibitor WXFL10030390</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD22 ADC TRPH-222</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ATR Kinase Inhibitor M1774</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vesencumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Diindolylmethane</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-1 Antibody-interleukin-21 Mutein Fusion Protein AMG 256</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Enclomiphene</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-1 Monoclonal Antibody CS1003</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Defactinib Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cyclophosphamide Anhydrous</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Indatuximab Ravtansine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aurora Kinase Inhibitor PF-03814735</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody HuPAM4</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mirdametinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Asulacrine Isethionate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">eIF4E Antisense Oligonucleotide ISIS 183750</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ginsenoside Rg3 Capsule</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bomedemstat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Universal CAR-expressing T-lymphocytes UniCAR02-T</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Molibresib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Proxalutamide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ocrelizumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CDH6 Antibody-drug Conjugate HKT288</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tyroserleutide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">cFMS Tyrosine Kinase Inhibitor ARRY-382</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-LAG3 Monoclonal Antibody TSR-033</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Guadecitabine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Everolimus Tablets for Oral Suspension</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Folate Receptor Targeted Epothilone BMS753493</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Liarozole Fumarate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cosibelimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">EGFR/FLT3/Abl Inhibitor SKLB1028</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aderbasib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ranpirnase</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oral Aminolevulinic Acid Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Antibody-Drug Conjugate DFRF4539A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Spebrutinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Calculus bovis/Moschus/Olibanum/Myrrha Capsule</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Edicotinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD20 Monoclonal Antibody-Interferon-alpha Fusion Protein IGN002</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Human Angiotensin Converting Enzyme 2 APN01</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Innate Immunostimulator rBBX-01</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-ErbB3 Monoclonal Antibody REGN1400</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ixazomib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oportuzumab Monatox</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Chloroquine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cisplatin-E Therapeutic Implant</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Other</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">FGF/FGFR Pathway Inhibitor E7090</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">FPV-Brachyury-TRICOM Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Epothilone KOS-1584</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CENP-E Inhibitor GSK-923295</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nitroglycerin Transdermal Patch</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Prostate Stem Cell Antigen-specific CAR T Cells BPX-601</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Herba Scutellaria Barbata</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Adenovirus 5/F35-Human Guanylyl Cyclase C-PADRE</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rituximab and Hyaluronidase Human</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">TSP-1 Mimetic ABT-510</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PSMA Monoclonal Antibody MLN591-DM1 Immunoconjugate MLN2704</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-L1 Monoclonal Antibody CBT-502</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tasadenoturev</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Timonacic</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dusigitumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Prime Cancer Vaccine MVA-BN-CV301</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Hexylresorcinol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sustained-release Lipid Inhaled Cisplatin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Camptothecin Sodium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing T-cells CT053</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD71/vcMMAE Probody-drug Conjugate CX-2029</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Xanthohumol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Batimastat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">WT1-A10/AS01B Immunotherapeutic GSK2130579A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Allogeneic CS1-specific Universal CAR-expressing T-lymphocytes UCARTCS1A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">VEGFR2/PDGFR/c-Kit/Flt-3 Inhibitor SU014813</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MET Tyrosine Kinase Inhibitor PF-04217903</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lutetium Lu 177-Edotreotide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rice Bran</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Coriolus Versicolor Extract</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aurora Kinase Inhibitor MLN8054</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ATM Inhibitor M 3541</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Soy Isoflavones</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sibrotuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Folate-FITC</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cobimetinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Telisotuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">pan-RAF Kinase Inhibitor TAK-580</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Iodine I 131 Monoclonal Antibody G-250</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vanucizumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Actinium Ac 225 Lintuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cycloleucine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ombrabulin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Artesunate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ERK Inhibitor CC-90003</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-1 Monoclonal Antibody BI 754091</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Onvansertib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PI3K-delta Inhibitor SHC014748M</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Copper Cu 64-ATSM</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Theliatinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lm-tLLO-neoantigens Vaccine ADXS-NEO</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-c-Met Monoclonal Antibody ABT-700</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD37 Bispecific Monoclonal Antibody GEN3009</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aclacinomycin B</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mavelertinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Conbercept</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Personalized Neoantigen DNA Vaccine GNOS-PV01</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cesalin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Poly-gamma Glutamic Acid</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Eflornithine Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-L1 Monoclonal Antibody LY3300054</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fascin Inhibitor NP-G2-044</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MVA Tumor-specific Neoantigen Boosting Vaccine MVA-209-FSP</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Hsp90 Inhibitor XL888</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">RET Inhibitor DS-5010</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Topoisomerase I Inhibitor LMP400</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">IL-12-expressing Mesenchymal Stem Cell Vaccine GX-051</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MEK Inhibitor SHR 7390</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">KRAS G12C Inhibitor GDC-6036</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Docetaxel Anhydrous</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Onalespib Lactate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Feladilimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">FLT3 Inhibitor HM43239</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sonepcizumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Denenicokin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody SGN-14</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD19/Anti-CD22 Bispecific Immunotoxin DT2219ARL</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Quinacrine Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nesvacumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Masitinib Mesylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PI3K-delta Inhibitor PWT143</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PI3K-beta Inhibitor GSK2636771</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-EGFR Monoclonal Antibody SCT200</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Src/Abl Kinase Inhibitor AZD0424</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">XIAP/cIAP1 Antagonist ASTX660</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Allogeneic CD3- CD19- CD57+ NKG2C+ NK Cells FATE-NK100</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Praluzatamab Ravtansine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Icotinib Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">O6-Benzylguanine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Stallimycin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CDK4 Inhibitor P1446A-05</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ormaplatin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Liposome-encapsulated miR-34 Mimic MRX34</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Actinium Ac 225-FPI-1434</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Mesenchymal Stem Cells Apceth_101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Antibody-drug Conjugate ABBV-176</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bispecific Antibody MDX-H210</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Trabedersen</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pexidartinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Topoisomerase I/II Inhibitor NEV-801</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">TM4SF1-CAR/EpCAM-CAR-expressing Autologous T Cells</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Src Kinase Inhibitor AP 23846</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pictilisib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cirmtuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sialyl Tn Antigen</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Thyroglobulin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Telomerase-specific Type 5 Adenovirus OBP-301</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Inproquone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MDM2 Inhibitor AMG-232</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rofecoxib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Samotolisib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">RARalpha Agonist IRX5183</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">T900607</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Piperine Extract (Standardized)</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BCR-ABL/KIT/AKT/ERK Inhibitor HQP1351</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Phenyl Acetate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Radioactive Iodine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CDC7 Kinase Inhibitor NMS-1116354</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Polysialic Acid</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Patidegib Topical Gel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Serine/Threonine Kinase Inhibitor CBP501</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PLGF Monoclonal Antibody TB-403</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lutetium Lu 177-PSMA-617</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Neoantigen-HSP70 Peptide Cancer Vaccine AGEN2017</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PI3K-alpha Inhibitor MEN1611</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-Ly6E Antibody-Drug Conjugate RG 7841</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-1 Monoclonal Antibody HLX10</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Voxtalisib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Yttrium Y 90 Daclizumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sergiolide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lutetium Lu-177 Capromab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Canerpaturev</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Halofuginone Hydrobromide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">p38 MAPK Inhibitor LY3007113</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monomethyl Auristatin E</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Androgen Receptor Degrader ARV-110</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Etigilimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ganetespib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">c-Met Inhibitor GST-HG161</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pentamethylmelamine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Atiprimod Dihydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aurora Kinase Inhibitor BI 811283</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-human GITR Monoclonal Antibody AMG 228</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Puromycin Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD47 Monoclonal Antibody TJC4</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-Folate Receptor-alpha Antibody Drug Conjugate STRO-002</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Personalized Neoepitope Yeast Vaccine YE-NEO-001</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Noscapine Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody Me1-14 F(ab')2</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Calicheamicin Gamma 1I</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Iridium Ir 192</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Trioxifene</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">mTOR Kinase Inhibitor AZD8055</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Tumor Infiltrating Lymphocytes LN-145-S1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Amcasertib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Liposome-Encapsulated Doxorubicin Citrate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bruceanol C</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PR1 Leukemia Peptide Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pamidronate Disodium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">KRASG12C Inhibitor JNJ-74699157</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Apomab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD19 Antibody-drug Conjugate SGN-CD19B</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-AXL Fusion Protein AVB-S6-500</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sulforaphane</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">STAT3 Inhibitor WP1066</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pan-mutation-selective EGFR Inhibitor CLN-081</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fadraciclib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-EGFR Monoclonal Antibody Mixture MM-151</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MDR Modulator CBT-1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">C/EBP Beta Antagonist ST101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Erythropoietin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rebeccamycin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous BCMA-targeted CAR T Cells LCAR-B4822M</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Roducitabine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mitoclomine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">JNK Inhibitor CC-401</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Caffeic Acid Phenethyl Ester</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD30/CD16A Monoclonal Antibody AFM13</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CSF-1R Inhibitor BLZ945</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PI3K/mTOR Kinase Inhibitor PF-04691502</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mannosulfan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Heterodimeric Interleukin-15</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Immunotherapeutic GSK1572932A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sumoylation Inhibitor TAK-981</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CDK1/2/4 Inhibitor AG-024322</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Allogeneic Large Multivalent Immunogen Melanoma Vaccine LP2307</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pibrozelesin Hydrobromide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD19 Monoclonal Antibody MEDI-551</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Human Plasminogen Kringle 5 Domain ABT 828</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Zirconium Zr 89 Panitumumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Barasertib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Antineoplastic Vaccine GV-1301</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vincristine Liposomal</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Protein Tyrosine Kinase 2 Inhibitor IN10018</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MET x MET Bispecific Antibody REGN5093</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Tumor Infiltrating Lymphocytes LN-144</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-KIR Monoclonal Antibody IPH 2101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Methoxyamine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Epitiostanol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">2-Methoxyestradiol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BRAF Inhibitor PLX8394</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vopratelimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nocodazole</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PSMA/CD3 Bispecific Antibody CCW702</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Colorectal Cancer Peptide Vaccine PolyPEPI1018</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-HER2 Antibody-drug Conjugate MEDI4276</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-AGS-5 Antibody-Drug Conjugate ASG-5ME</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Iodine I 131 Tenatumomab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pinatuzumab Vedotin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-HER2 Immune Stimulator-antibody Conjugate NJH395</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Relugolix</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">SBIL-2</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Etoposide Toniribate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Enadenotucirev-expressing FAP/CD3 Bispecific FAP-TAc NG-641</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mps1 Inhibitor BOS172722</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Y 90 Monoclonal Antibody m170</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Silibinin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PIM Kinase Inhibitor SGI-1776</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Yttrium Y-90 Clivatuzumab Tetraxetan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Adenosine A2A Receptor Antagonist CS3005</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Afatinib Dimaleate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Losoxantrone Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oral Picoplatin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Elacytarabine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Alvespimycin Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Yttrium Y 90 Anti-CD19 Monoclonal Antibody BU12</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Methylmercaptopurine Riboside</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PI3Kdelta Inhibitor GS-9901</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rose Bengal Solution PV-10</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti c-KIT Antibody-drug Conjugate LOP628</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Clofarabine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Polatuzumab Vedotin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">SIRPa-Fc-CD40L Fusion Protein SL-172154</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nelipepimut-S</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">TSP-1 Mimetic Fusion Protein CVX-045</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Polo-like Kinase 4 Inhibitor CFI-400945 Fumarate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BET Inhibitor INCB054329</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sedoxantrone Trihydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lapuleucel-T</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">11C Topotecan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">c-Met Inhibitor MK8033</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-L1 Monoclonal Antibody BGB-A333</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HER2 Inhibitor TAS0728</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD52 Monoclonal Antibody ALLO-647</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CTLA-4-directed Probody BMS-986249</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MEK-1/MEKK-1 Inhibitor E6201</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Neoantigen Vaccine GEN-009</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-LAG-3 Monoclonal Antibody REGN3767</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">JAK2 Inhibitor BMS-911543</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Demplatin Pegraglumer</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Multikinase Inhibitor SAR103168</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous CD19-targeted CAR T Cells CC-97540</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CA19-9 Monoclonal Antibody 5B1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Giloralimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Naratuximab Emtansine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">IDO/TDO Inhibitor HTI-1090</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Paclitaxel Trevatide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">c-raf Antisense Oligonucleotide ISIS 5132</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">VEGFR/FGFR Inhibitor ODM-203</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Antroquinonol Capsule</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HIF2a RNAi ARO-HIF2</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Golvatinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody A1G4 Anti-Idiotype Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Patritumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">IL4-Pseudomonas Exotoxin Fusion Protein MDNA55</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Leukoregulin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Antitumor B Key Active Component-alpha</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mitochondrial Oxidative Phosphorylation Inhibitor ATR-101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HDAC Class I/IIb Inhibitor HG146</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pravastatin Sodium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD73 Monoclonal Antibody NZV930</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tyrosine Kinase Inhibitor SU5402</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Interferon Alfa-1b</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oncolytic HSV1716</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-BCMA Antibody-drug Conjugate GSK2857916</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fluzoparib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Milciclib Maleate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Engineered Red Blood Cells Co-expressing 4-1BBL and IL-15TP RTX-240</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">JAK2/Src Inhibitor NS-018</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Glutaminase Inhibitor CB-839 Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Abemaciclib Mesylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Iodine I 131 TM-601</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Licorice</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Favezelimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine MEDI0457</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Clomiphene</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Methyltestosterone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Crystalline Genistein Formulation AXP107-11</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Hsp90 Inhibitor Debio 0932</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">pan-RAF Inhibitor LXH254</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sodium Borocaptate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD20 Monoclonal Antibody B001</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">P-cadherin Antagonist PF-03732010</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">SRPK1/ABCG2 Inhibitor SCO-101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Elbasvir/Grazoprevir</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Breflate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Selumetinib Sulfate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous CAR-mbIL15-Safety Switch T-cells PRGN-3005</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Thioguanine Anhydrous</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-EGFR Monoclonal Antibody EMD 55900</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Histone-Lysine N-Methyltransferase EZH2 Inhibitor GSK2816126</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-ErbB3/Anti-IGF-1R Bispecific Monoclonal Antibody MM-141</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HDAC Inhibitor MPT0E028</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ganglioside GD2</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dupilumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">p53/HDM2 Interaction Inhibitor CGM097</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ras Peptide ASP</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">FAK Inhibitor PF-00562271</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Murizatoclax</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">DM-CHOC-PEN</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-HLA-DR Monoclonal Antibody IMMU-114</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-1 Monoclonal Antibody MEDI0680</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Farnesyltransferase/Geranylgeranyltransferase Inhibitor L-778,123</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Antibody-drug Conjugate PF-06647263</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Rapamycin-resistant Th1/Tc1 Cells RAPA-201</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Hexamethylene Bisacetamide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">SLCT Inhibitor GNS561</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Diazooxonorleucine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-IL-1 alpha Monoclonal Antibody MABp1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Relatlimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Alvespimycin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Delolimogene Mupadenorepvec</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Acitretin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Alvocidib Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cytochlor</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Morinda Citrifolia Fruit Extract</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Galamustine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Topoisomerase-1 Inhibitor LMP744</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Erlotinib Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Uracil Ointment</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Resiquimod</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bruceanol E</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mycobacterium tuberculosis Arabinomannan Z-100</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MVA-BN Smallpox Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatases Isoform 3 Inhibitor ACT-PFK-158</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD19-DM4 Immunoconjugate SAR3419</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lexibulin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Natalizumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Derazantinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Doxazosin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">TAM/c-Met Inhibitor RXDX-106</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lifastuzumab Vedotin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bisnafide Dimesylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Gemcitabine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Allogeneic Anti-CD19 Universal CAR-T Cells CTA101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Resveratrol Formulation SRT501</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Trimeric GITRL-Fc OMP-336B11</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Belantamab Mafodotin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fluorouracil-E Therapeutic Implant</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Polyethyleneglycol-7-ethyl-10-hydroxycamptothecin DFP-13318</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Iboctadekin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Apolizumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Inodiftagene Vixteplasmid</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Caricotamide/Tretazicar</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Therapeutic Angiotensin-(1-7)</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Raloxifene Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tubulin Polymerization Inhibitor AEZS 112</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Acalabrutinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aurora A Kinase Inhibitor LY3295668</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-S15 Monoclonal Antibody NC318</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Peretinoin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Piroxantrone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">IDO/TDO Inhibitor LY-01013</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nilotinib Hydrochloride Anhydrous</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Selicrelumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Androgen Receptor/Glucocorticoid Receptor  Antagonist CB-03-10</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Salirasib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">SDF-1 Receptor Antagonist PTX-9908</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Allogeneic Plasmacytoid Dendritic Cells Expressing Lung Tumor Antigens PDC*lung01</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anhydrovinblastine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Liposomal Irinotecan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">FAK/ALK/ROS1 Inhibitor APG-2449</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dacplatinum</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Isotretinoin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Iodine I 131 Apamistamab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Drozitumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">5-Fluoro-2-Deoxycytidine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Platelet Factor 4</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Didox</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Anti-PD-1 Antibody-activated Tumor-infiltrating Lymphocytes</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Hsp90 Inhibitor PU-H71</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-TIGIT Monoclonal Antibody BMS-986207</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Zorubicin Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">DNA Plasmid Encoding Interleukin-12 INO-9012</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BCG Solution</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sodium Selenite</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rosopatamab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pemetrexed</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Astatine At 211 Anti-CD38 Monoclonal Antibody OKT10-B10</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pingyangmycin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Motexafin Lutetium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Amatuximab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD137 Agonistic Monoclonal Antibody LVGN6051</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Selective Estrogen Receptor Degrader LY3484356</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Polo-like Kinase 1 Inhibitor GSK461364</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">FAK Inhibitor GSK2256098</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-TIM-3 Antibody BMS-986258</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tyrosine Kinase Inhibitor</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">IL-10 Immunomodulator MK-1966</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tavolimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vinepidine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Liposomal Topotecan FF-10850</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Olutasidenib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">mRNA-based Tumor-specific Neoantigen Boosting Vaccine GRT-R902</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">RAF Kinase Inhibitor XL281</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bemarituzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD1 Monoclonal Antibody AGEN2034</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pelabresib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Emofolin Sodium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Tumor Infiltrating Lymphocytes MDA-TIL</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HDM2 Inhibitor HDM201</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Light-Emitting Oncolytic Vaccinia Virus GL-ONC1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">DPT/BCG/Measles/Serratia/Pneumococcus Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HLA-A*0201 Restricted TERT(572Y)/TERT(572) Peptides Vaccine Vx-001</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Talabostat Mesylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sparfosic Acid</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Navitoclax</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-GITR Agonistic Monoclonal Antibody BMS-986156</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pegilodecakin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Multi-AGC Kinase Inhibitor AT13148</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Binimetinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mercaptopurine Oral Suspension</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Polo-like Kinase 1 Inhibitor MK1496</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-HA Epitope Monoclonal Antibody MEDI8852</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Incyclinide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Idronoxil Suppository NOX66</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD70 Antibody-drug Conjugate SGN-CD70A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tirabrutinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Quizartinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-TROP2/DXd Antibody-drug Conjugate DS-1062a</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CDC7 Kinase Inhibitor LY3143921 Hydrate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pegvisomant</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ditiocarb</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Agonistic Anti-CD40 Monoclonal Antibody ADC-1013</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD137 Agonistic Monoclonal Antibody ATOR-1017</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-angiopoietin Monoclonal Antibody AMG 780</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Eribulin Mesylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody 81C6</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rebimastat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-RANKL Monoclonal Antibody GB-223</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-EphA2 Monoclonal Antibody DS-8895a</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Allogeneic CRISPR-Cas9 Engineered Anti-BCMA T Cells CTX120</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monocarboxylate Transporter 1 Inhibitor AZD3965</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tubulin Polymerization Inhibitor CKD-516</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Adenovirus-expressing TLR5/TLR5 Agonist Nanoformulation M-VM3</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">FACT Complex-targeting Curaxin CBL0137</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aminopterin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Panitumumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">KRN5500</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Acodazole Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD30 Monoclonal Antibody XmAb2513</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Gutolactone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Perifosine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody A33</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CBP/beta-catenin Antagonist PRI-724</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CSF1R Inhibitor ABSK021</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-GD2 Monoclonal Antibody hu14.18K322A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Survivin-expressing CVD908ssb-TXSVN Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Irosustat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD123/CD3 Bispecific Antibody JNJ-63709178</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vinorelbine Tartrate Oral</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CYP17 Lyase Inhibitor ASN001</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant MAGE-3.1 Antigen</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">TGF-beta Receptor 1 Kinase Inhibitor YL-13027</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Brilanestrant</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lirilumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Anti-CD123 CAR-T Cells</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Temsirolimus</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">H1299 Tumor Cell Lysate Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Photodynamic Compound TLD-1433</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">EGFR T790M Inhibitor HS-10296</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Gelonin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Piritrexim Isethionate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Micellar Nanoparticle-encapsulated Epirubicin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Laprituximab Emtansine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aurora B/C Kinase Inhibitor GSK1070916A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Antibody-drug Conjugate SC-003</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Patupilone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">F16-IL2 Fusion Protein</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dengue Virus Adjuvant PV-001-DV</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Antibody-like CD95 Receptor/Fc-fusion Protein CAN-008</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bruceantin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dezaguanine Mesylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">IDO Peptide Vaccine IO102</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-integrin Beta-6/MMAE Antibody-drug Conjugate SGN-B6A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Liposomal MUC1/PET-lipid A Vaccine ONT-10</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Arabinoxylan Compound MGN3</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BTK Inhibitor ICP-022</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Extended Release Metformin Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Odronextamab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Infigratinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-HER2 Antibody-drug Conjugate A166</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Thorium Th 227 Anetumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ribozyme RPI.4610</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mitazalimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oxidative Phosphorylation Inhibitor IM156</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Linrodostat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anlotinib Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Daromun</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tanibirumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Plocabulin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Narnatumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD27L Antibody-Drug Conjugate AMG 172</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Chemotherapy</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Busulfan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Poly-alendronate Dextran-Guanidine Conjugate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Splicing Inhibitor H3B-8800</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Not Otherwise Specified</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Simtuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Gemcitabine Prodrug LY2334737</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oxeclosporin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Thymidylate Synthase Inhibitor CX1106</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Procaspase Activating Compound-1 VO-100</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dolastatin 10</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-VEGFR2 Monoclonal Antibody HLX06</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Larotaxel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Long-acting Release Pasireotide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous CD20-4SCAR-expressing T-cells 4SCAR20</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD19/CD3 BiTE Antibody AMG 562</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Emepepimut-S</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Goserelin Acetate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">IAP Inhibitor AT-406</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-FRA/Eribulin Antibody-drug Conjugate MORAb-202</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-EGFRvIII Immunotoxin MR1-1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lutetium Lu 177-NeoB</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">SMO Protein Inhibitor ZSP1602</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CXCR4 Peptide Antagonist LY2510924</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Niacinamide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Leuprolide Mesylate Injectable Suspension</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ilginatinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Itraconazole Dispersion In Polymer Matrix</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tin Ethyl Etiopurpurin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-Globo H/MMAE Antibody-drug Conjugate OBI 999</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Taladegib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rivoceranib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CTLA-4 Probody BMS-986288</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Iratumumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vincristine Sulfate Liposome</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Iobenguane I-131</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody L6</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CTLA-4/OX40 Bispecific Antibody ATOR-1015</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Gilteritinib Fumarate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Everolimus</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nazartinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ramucirumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-Neuropilin-1 Monoclonal Antibody MNRP1685A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tariquidar</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lutetium Lu 177 DOTA-N3-CTT1403</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lysine-specific Demethylase 1 Inhibitor INCB059872</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-MUC16/MMAE Antibody-Drug Conjugate DMUC4064A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cevipabulin Succinate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Elotuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody Hu3S193</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Galeterone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-KSP/Anti-VEGF siRNAs ALN-VSP02</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nanoparticle Albumin-Bound Docetaxel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lucatumumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-GnRH Vaccine PEP223</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">JAK2 Inhibitor AZD1480</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">AXL Inhibitor SLC-391</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-ENPP3 Antibody-Drug Conjugate AGS-16C3F</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sam68 Modulator CWP232291</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-c-KIT Monoclonal Antibody CDX 0158</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Hsp90 Inhibitor BIIB021</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pipendoxifene</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">IDH1R132H-Specific Peptide Vaccine PEPIDH1M</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">2-Fluorofucose-containing SGN-2FF</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Decitabine and Cedazuridine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Transdermal 4-Hydroxytestosterone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Apricoxib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dalantercept</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Agerafenib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-BCMA SparX Protein Plus BCMA-directed Anti-TAAG ARC T-cells CART-ddBCMA</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">TLR Agonist CADI-05</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oral Sodium Phenylbutyrate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Iadademstat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mercaptopurine Anhydrous</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-GD2 hu3F8/Anti-CD3 huOKT3 Bispecific Antibody</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-HER2 Antibody-drug Conjugate ARX788</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ixazomib Citrate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MEK Inhibitor AZD8330</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-OFA Immunotherapeutic BB-MPI-03</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MTF-1 Inhibitor APTO-253 HCl</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BRAF Inhibitor BGB-3245</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">p70S6K Inhibitor LY2584702</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">KRAS Mutant-targeting AMG 510</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CDK4/6 Inhibitor G1T38</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PKC-alpha Antisense Oligodeoxynucleotide ISIS 3521</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pomegranate Liquid Extract</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Taselisib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Retinoid 9cUAB30</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tranylcypromine Sulfate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Talazoparib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bizelesin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Belzutifan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">DNA-PK/PI3K-delta Inhibitor BR101801</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nanosomal Docetaxel Lipid Suspension</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Melanoma TRP2 CTL Epitope Vaccine SCIB1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Selective Estrogen Receptor Degrader LSZ102</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Clostridium Novyi-NT Spores</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mechlorethamine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Idasanutlin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">FLT3/FGFR Dual Kinase Inhibitor MAX-40279</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fulvestrant</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-ErbB2/Anti-ErbB3 Bispecific Monoclonal Antibody MM-111</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Estramustine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Glutamine Antagonist DRP-104</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Iodine I 131 Ethiodized Oil</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Interferon Alfa-2b</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Gemcitabine Elaidate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MDM2 Antagonist RO6839921</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PD-L1/4-1BB/HSA Trispecific Fusion Protein NM21-1480</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Synchrotope TA2M Plasmid DNA Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">EphA2-targeting Bicycle Toxin Conjugate BT5528</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Human Monoclonal Antibody 216</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">I 131 Monoclonal Antibody CC49</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Hydroxytyrosol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Alisertib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Acetylcysteine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oxcarbazepine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Orantinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MEK Inhibitor CI-1040</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Varlilumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Super Enhancer Inhibitor GZ17-6.02</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody NEO-201</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pracinostat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Idetrexed</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-NRP1 Antibody ASP1948</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tegafur-Gimeracil-Oteracil Potassium-Leucovorin Calcium Oral Formulation</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sivifene</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PSMA-targeted Tubulysin B-containing Conjugate EC1169</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PI3Ka/mTOR Inhibitor PKI-179</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-ErbB3 Monoclonal Antibody CDX-3379</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Engineered Toxin Body Targeting CD38 TAK-169</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Topoisomerase-II Inhibitor Racemic XK469</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ovarian Cancer Stem Cell/hTERT/Survivin mRNAs-loaded Autologous Dendritic Cell Vaccine DC-006</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tapotoclax</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Iproplatin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HuaChanSu</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Factor VIIa Inhibitor PCI-27483</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Sho-Saiko-To</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mirabegron</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nitrogen Mustard Prodrug PR-104</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dexamethasone Phosphate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ensartinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-EGFRvIII/CD3 BiTE Antibody AMG 596</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pan-RAR Agonist/AP-1 Inhibitor LGD 1550</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CCR4 Inhibitor FLX475</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">SERD SHR9549</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pidilizumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Mesothelin-specific Human mRNA CAR-transfected PBMCs MCY-M11</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rocakinogene Sifuplasmid</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Deoxycytidine Analogue TAS-109</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Human Endostatin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Protein Stabilized Liposomal Docetaxel Nanoparticles</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CTLA-4 Monoclonal Antibody ONC-392</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">DR5 HexaBody Agonist GEN1029</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-Claudin18.2 Monoclonal Antibody TST001</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-GD3 Antibody-drug Conjugate PF-06688992</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Seribantumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nutlin-3a</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Darinaparsin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Patritumab Deruxtecan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Photosensitizer LUZ 11</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HPV-6-targeting Immunotherapeutic Vaccine INO-3106</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">alpha-Folate Receptor-targeting Thymidylate Synthase Inhibitor ONX-0801</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bintrafusp Alfa</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vantictumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dasatinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PI3K/mTOR/ALK-1/DNA-PK Inhibitor P7170</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Teniposide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Avadomide Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Multi-mode Kinase Inhibitor EOC317</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Hexaminolevulinate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cergutuzumab Amunaleukin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CDK8/19 Inhibitor SEL 120</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Selective Glucocorticoid Receptor Antagonist CORT125281</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aglatimagene Besadenovec</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Epacadostat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cancer Peptide Vaccine S-588410</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Platinum Acetylacetonate-Titanium Dioxide Nanoparticles</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cyproterone Acetate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Semaxanib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Dendrimer-conjugated Bcl-2/Bcl-XL Inhibitor AZD0466</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Shark Cartilage Extract AE-941</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fosifloxuridine Nafalbenamide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Calcium Release-activated Channel Inhibitor CM4620</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lenvatinib Mesylate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Docetaxel Emulsion ANX-514</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vinblastine Sulfate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Toremifene Citrate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Simlukafusp Alfa</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tidutamab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mavorixafor</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pegylated Paclitaxel</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vascular Disrupting Agent BNC105</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">AKT 1/2 Inhibitor BAY1125976</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Selective Estrogen Receptor Degrader AZD9496</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BET-bromodomain Inhibitor ODM-207</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-NaPi2b Antibody-drug Conjugate XMT-1592</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Semustine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vorasidenib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Immunomodulator LAM-003</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Letolizumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Antibody-drug Conjugate ADC XMT-1536</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD22 Monoclonal Antibody-MMAE Conjugate DCDT2980S</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BRAF Inhibitor ARQ 736</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Gimatecan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Arsenic Trioxide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vosaroxin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Androgen Antagonist APC-100</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">14C BMS-275183</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Interferon Gamma</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Deferoxamine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Enoblituzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Verubulin Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PD-1 Inhibitor</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Allogeneic Anti-BCMA CAR-transduced T-cells ALLO-715</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">P-cadherin-targeting Agent PF-06671008</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Idarubicin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Shared Anti-Idiotype-AB-S024A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bendamustine-containing Nanoparticle-based Formulation RXDX-107</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Carotuximab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vesigenurtucel-L</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Thiotepa</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mirvetuximab Soravtansine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CEA/Anti-DTPA-In (F6-734) Bispecific Antibody</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Losatuxizumab Vedotin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Indoximod Prodrug NLG802</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Angiogenesis Inhibitor GT-111</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD39 Monoclonal Antibody SRF617</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Golnerminogene Pradenovec</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">RNR Inhibitor COH29</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Silatecan AR-67</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MDM2 Inhibitor BI 907828</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">RIPK1 Inhibitor GSK3145095</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Diphtheria Toxin Fragment-Interleukin-2 Fusion Protein E7777</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Dendritic Cell-based Immunotherapeutic AV0113</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Resminostat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Iodine I 124 Monoclonal Antibody M5A</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Antibody-drug Conjugate Anti-TIM-1-vcMMAE CDX-014</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Triplatin Tetranitrate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tipapkinogene Sovacivec</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">iPSC-derived CD16/IL-15RF-expressing Anti-CD19 CAR-NK Cells FT596</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Beta-Carotene</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Valecobulin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">VGEF Mixed-Backbone Antisense Oligonucleotide GEM 220</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-GITR Monoclonal Antibody GWN 323</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Anti-BCMA CD8+ CAR T-cells Descartes-11</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Efizonerimod</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Natural Killer Cells ZRx101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pan-VEGFR/TIE2 Tyrosine Kinase Inhibitor CEP-11981</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Paclitaxel Injection Concentrate for Nanodispersion</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Fosgemcitabine Palabenamide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Selective Estrogen Receptor Degrader SRN-927</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tilsotolimod Sodium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Heat-Shock Protein 70 Peptide Vaccine AG-858</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Gallium-based Bone Resorption Inhibitor AP-002</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PI3K Alpha/Beta Inhibitor BAY1082439</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">TLR7/8/9 Antagonist IMO-8400</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Acyclic Nucleoside Phosphonate Prodrug ABI-1968</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">N,N-Dibenzyl Daunomycin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Liarozole</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MKNK1 Inhibitor BAY 1143269</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody HuHMFG1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MEK Inhibitor GDC-0623</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vadastuximab Talirine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ATM Kinase Inhibitor AZD0156</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Daratumumab/rHuPH20</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cationic Peptide Cream Cypep-1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bisantrene Hydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Flanvotumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-HLA-G Antibody TTX-080</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Luteinizing Hormone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Ivaltinostat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Entrectinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">2-Hydroxyflutamide Depot</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Detirelix</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Medroxyprogesterone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oral Pancreatic Cancer Vaccine V3-P</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-MMP-9 Monoclonal Antibody GS-5745</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Streptonigrin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Mcl-1 Inhibitor MIK665</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Talacotuzumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Iberdomide</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Minretumomab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">p97 Inhibitor CB-5083</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">PV-10</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">MDM2 Inhibitor KRT-232</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Citatuzumab Bogatox</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Leuprolide Acetate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Picropodophyllin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Atuveciclib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous Nectin-4/FAP-targeted CAR-T Cells</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Altiratinib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tomivosertib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Elsamitrucin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-gremlin-1 Monoclonal Antibody UCB6114</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">STAT3 Inhibitor OPB-31121</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Acronine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD25 Monoclonal Antibody RO7296682</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Autologous CD123-4SCAR-expressing T-cells 4SCAR123</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lurbinectedin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Loncastuximab Tesirine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Bruceanol D</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Duvelisib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Olaparib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD40L Fc-Fusion Protein BMS-986004</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aprinocarsen</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Halofuginone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Iodine I 124 Monoclonal Antibody A33</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">TIGIT Inhibitor M6223</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Apatorsen</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cytarabine Monophosphate Prodrug MB07133</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Iso-fludelone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Transferrin Receptor-Targeted Anti-RRM2 siRNA CALAA-01</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Retinyl Palmitate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Thorium Th 227 Anetumab Corixetan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody huJ591</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BF-200 Gel Formulation</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Curcumin/Doxorubicin-encapsulating Nanoparticle IMX-110</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Olaptesed Pegol</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tegafur</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">EZH1/2 Inhibitor DS-3201</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Aniline Mustard</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Porcupine Inhibitor ETC-1922159</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tyrosinase-KLH</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HER2-directed TLR8 Agonist SBT6050</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Irinotecan Sucrosofate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-Globo H Monoclonal Antibody OBI-888</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-c-Met Monoclonal Antibody ARGX-111</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">DNA Vaccine VB10.16</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Coxsackievirus A21</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD20/CD3 Monoclonal Antibody REGN1979</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">TRAIL Receptor Agonist ABBV-621</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Adenovirus Serotype 26-expressing HPV16 Vaccine JNJ-63682918</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Recombinant Transforming Growth Factor-Beta</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Interferon</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Monoclonal Antibody 3H1 Anti-Idiotype Vaccine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Emitefur</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Zebularine</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Entolimod</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">BET Inhibitor INCB057643</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-PD-L1 Monoclonal Antibody IMC-001</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Glasdegib Maleate</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Lutetium Lu 177 Monoclonal Antibody J591</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Licartin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Pan-AKT Kinase Inhibitor GSK690693</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Cevostamab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">HDAC Inhibitor CXD101</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Nolatrexed Dihydrochloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Smoothened Antagonist TAK-441</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Troglitazone</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Oglufanide Disodium</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">ADH-1</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CEACAM5 Antibody-Drug Conjugate SAR408701</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Foslinanib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">pbi-shRNA STMN1 Lipoplex</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Osilodrostat</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Serabelisib</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Teglarinad Chloride</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Tiragolumab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-OX40 Monoclonal Antibody GSK3174998</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Esterified Estrogens</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Vibostolimab</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Yttrium Y-90 Tacatuzumab Tetraxetan</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Rhizoxin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Indibulin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CD40 Monoclonal Antibody SEA-CD40</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">CDC7 Kinase Inhibitor BMS-863233</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Phosphatidylcholine-Bound Silybin</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
<tr>
<td align="left">Anti-CSF1 Monoclonal Antibody PD-0360324</td>
<td align="center"></td>
<td align="center"></td>
<td align="right"></td>
</tr>
</tbody>
</table>
                
              
              
                


              
            </article>
          </div>
        </div>
        
      </main>
      
        
<footer class="md-footer">
  
  <div class="md-footer-meta md-typeset">
    <div class="md-footer-meta__inner md-grid">
      <div class="md-footer-copyright">
        
        Made with
        <a href="https://squidfunk.github.io/mkdocs-material/" target="_blank" rel="noopener">
          Material for MkDocs
        </a>
        
      </div>
      
    </div>
  </div>
</footer>
      
    </div>
    <div class="md-dialog" data-md-component="dialog">
      <div class="md-dialog__inner md-typeset"></div>
    </div>
    <script id="__config" type="application/json">{"base": "..", "features": [], "translations": {"clipboard.copy": "Copy to clipboard", "clipboard.copied": "Copied to clipboard", "search.config.lang": "en", "search.config.pipeline": "trimmer, stopWordFilter", "search.config.separator": "[\\s\\-]+", "search.placeholder": "Search", "search.result.placeholder": "Type to start searching", "search.result.none": "No matching documents", "search.result.one": "1 matching document", "search.result.other": "# matching documents", "search.result.more.one": "1 more on this page", "search.result.more.other": "# more on this page", "search.result.term.missing": "Missing"}, "search": "../assets/javascripts/workers/search.d351de03.min.js", "version": {"provider": "mike"}}</script>
    
    
      <script src="../assets/javascripts/bundle.34eae1b6.min.js"></script>
      
    
  </body>
</html>